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                                                     ABSTRACT  
Evaluation of Visual Evoked Potential and Brainstem Auditory Evoked Potential In    
                                                           Migraine   
Aim : The  present study was undertaken to investigate the visual and brainstem auditory  
functions in Migraine patients.  
Materials And Methods : The subjects were recruited  from  Out patient Clinic  of  
Department of  Neuromedicine, Thanjavur  Medical College & Hospital , Thanjavur  
based on International Headache Society classification  for Migraine. Subjects with 
history suggestive of other types of headache, TTH , cluster headache , sinusitis  and 
subjects with Visual field defects , Auditory deficits are excluded from the study . Forty 
subjects ( 16 with Aura & 24 cases – Migraine without aura ) in the mean age group of 19 
to 52 yrs & forty age / sex matched controls with no history  of Headache were selected 
for the study. Informed written   consent was obtained from the subject. Ethical 
committee approval was obtained from the Institution before commencing the study. A 
detailed   history of Headache duration, frequency and history suggestive of aura and 
history to rule out other types of headache were noted. Ophthalmologic examination was 
done to determine visual acuity, Field of Vision, extraocular movements and pupillary 
diameter. The results were analysed  statistically  using  student „t‟ test .  
Results : There was significant prolongation of  P100  & N145 latency (p<0.05) in both 
Migraine with aura and without aura compared with controls. BAEP recording shows 
significant prolongation of latency of Wave I, III & V and the Interpeak latency I-III, III-
V & I-V in Migraine with aura. In Migraine without aura, there was significant 
prolongation of Wave I, III & V and   only III-V IPL & I-V IPL. (p<0.05). 
Keywords : Migraine , Aura , Visual evoked potential , Brainstem auditory evoked 
potential. 
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                                           INTRODUCTION 
                Headache is one of the most frequently encountered Neurological symptom.
(1)
  
Headache  is caused by irritation of pain sensitive Intracranial structures like Dural 
sinuses , intracranial portions of Trigeminal , Glossopharyngeal ,Vagus and upper 
Cervical nerves ;large arteries and venous sinuses. The structures which are insensitive to 
pain are Brain parenchyma, Ependymal lining of ventricles and the Choroid plexus
.(2)
 
                    Painful stimuli arising from the brain tissue above the Tentorium cerebelli  
are transmitted via Trigeminal nerve whereas impulses from posterior fossa are conveyed 
by Glossopharyngeal ,vagus and upper  two cervical nerves.
(2)
 
                  Headache disorders can be classified into 
                                     1. Primary Headache disorder  
                                     2. Headache secondary to structural brain disease 
      Primary Headaches are disorders in which headache and associated features occur in 
the absence of exogenous cause. Migraine, Tension type headache and Cluster headache 
are most common Primary headache syndromes.
 (3) 
            Migraine is the disorder of the brain characterized by complex sensory 
dysfunction.
(4)
It is an Episodic headache disorder and second most common type of 
primary headache.
(2,3) 
Migraine occurs at any age either at childhood , adolescent and 
adult life , more common in Females than Males in the ratio of 3:1. 60% of patients have 
positive Family history.
(5)
                                                         
           Migraine  has  a great impact on mental , physical , functional and socioeconomic  
aspects of   patient „s life.(6) Migrainous  have higher lifetime  risk of Depressive  
disorder, Panic  disorder, OCD , Generalised  Anxiety disorder , phobias  and  Suicide 
attempts than the normal subjects.
(7)  
 
           The Diagnosis of Migraine was based on headache characteristics and associated 
symptoms which is subjective.
(2)
 Routine Clinical Examination and Testing for Visual 
function also appears to be normal in Migraine patients. So, Electrophysiological and 
Psychophysical tests have been carried out in Migraine patients.
(6)
 
    
 
            The Migraineous brain is hyperexcitable not only during the attack but also in 
between attack i.e., the interictal phase. There is specific involvement of visual system in 
Migraine patients. Migraineous aura is visual in about 82 to 90% of cases.
(6)
Due to 
frequent occurrence of  visual symptoms and due to impairment of Visual processing in 
Migraine many studies are oriented towards evaluation of  VEP changes in Migraine 
patients which is a simple and Non-invasive test .
(8)
 
         Migraine attacks also originate due to abnormal Nociceptive Neuromodulator   
centers especially the Monoaminergic sensory control systems located in the Brainstem. 
Neuro-otological symptoms like vertigo, phonophobia, tinnitus, unsteadiness and hearing 
loss are also common in Migraine. There is a mild bilateral and reversible auditory & 
vestibular hypofunction during Migraine attack. So, BAEP can be done to assess the 
function of Brainstem structures traversed by auditory pathways.  
             Functional and Electrophysiological alterations in cortical functioning also found, 
an association between   Cognitive impairment and   Migraine attack.
(7) 
 
                  Hence, Electrophysiological tests like Visual Evoked Potential and Brainstem 
Auditory Evoked Potential are done in Migraine patients to better understand the 
pathogenesis of Migraine and to utilize these tests for Diagnosis and Effective 
management of Migraine. 
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                                  AIMS    AND   OBJECTIVES 
 
1.  To   investigate   and  compare   the   visual  function  and  Auditory  function   
in  Migraine patients  and  healthy  controls. 
2. This   study  was  undertaken   to  evaluate  Electrophysiological   parameters  
VEP and  BAEP  in  Migraine  patients   with  and  without Aura  compared   
with  controls. 
3. To evaluate the role of   VEP and BAEP in the diagnosis of Migraine. 
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                               REVIEW   OF  LITERATURE 
                           Migraine is worldwide common, chronic, incapacitating Neurovascular 
disorder, characterized by attacks of severe headache, Autonomic nervous system 
dysfunction and an Aura involving neurologic symptoms. Individuals with Migraine 
appear to process Auditory and Visual information differently from those without 
Migraine.
( 7)
 
HISTORY: 
         It was Arateus of Cappadocia in the 2
nd
 century AD first identified many of the 
features   of Migraine. Galen in 200 AD  named illness  using the Greek , as Hemicrania 
to describe periodic disorder that comprises paroxysmal and blinding hemicranial pain 
from which the term corrupted to latin “Hemigranea and Migranea”  and finally the 
French translation “Migraine” was obtained in the 18th century.(9)In 1988, the 
International Headache Society published Guidelines for classification of  Headache 
types. Then, Stewart and Lipton published the American Migraine study
.(10)
 
EPIDEMIOLOGY: 
          The Lifetime prevalence of Migraine is   about   20% in Females   and   6% in 
Males. Migraine may begin at any Age, from early Childhood, although peak age of 
onset is Adolescent and early Adulthood. 
(2)
 Over 90% of sufferers have their first attack 
by 30yrs of age and commonly affects the working individuals in the population. 
(1)
This   
chronic illness is widespread   among the population, 10% diagnosed & 5 % undiagnosed 
with seriousness varying   from mild distress to   chronic daily headache. 
 ETIOLOGY: 
           Etiology of Migraine is largely unknown. Proposed causes are 
1. Family history suggests Genetic predisposition, positive history is present in 60 
to 90 %   of cases. One type of Migraine called Familial Hemiplegic Migraine 
is due to mutation in a gene for P/Q type calcium channel on Chr.19 and a gene 
encoding   Sodium – Potassium ion pump on Chr.1. The calcium channels 
cause serotonin release in the Midbrain. So, dysfunction of these channels, 
impair serotonin release and predispose   to Migraine attack. The release of 
CGRP , a  Neuropeptide also play a role in Migraine as it is a potent 
vasodilator.
(2)
 
2. Female preponderance suggests Hormonal influence. Some women have 
Migraine only around the Menstrual period called Menstrual Migraine which is 
more intense and  last longer.
(11)
 
3. Dietary  precipitants – diet  such as  cheese , chocolate and red wine can  
precipitate an attack of  Migraine.
(5)
 
4. Stress - often trigger an attack in about 70% of cases. Stress may be of 
Endogenous (eg.Hormone), Exogenous, psychological stress like Emotional, 
socioeconomic and social stress. These repeated stressors lead to changes in 
the brain state , characterized  by  Cortical Excitability , changes in brain 
Morphology and changes in Behavior.
(11)
 
5. Headache can be initiated or amplified  by various triggers  like glare , bright 
lights , sounds  or other afferent stimulation ; Hunger, Excess stress , physical 
exertion , stormy weather  or barometric pressure changes , excess sleep or  
 lack of sleep  , alcohol  or other  chemical  stimulation  can precipitate an 
attack.
(3)
 
Acute Migraine attack depends upon the individual„s inherent level of 
Vulnerability to an attack. The lower the threshold, the greater the    
vulnerability  for   Migraine. 
CLASSIFICATION :
(12)
 
                    Several varieties of Migraine are present.  
1. Migraine without Aura ( common Migraine ) 
2. Migraine with Aura ( classic Migraine) 
3. Complicated Migraine 
4. Hemiplegic Migraine 
5. Ophthalmoplegic Migraine  
6. Basilar Migraine  
7. Facioplegic Migraine  
8. Retinal Migraine  
1. COMMON   MIGRAINE: 
       Migraine without Aura accounts for 80% of cases. A prodrome may occur     
24hrs preceding the headache. Prodromal features are hunger, thirst, euphoria, mania, 
depression, psychomotor slowing or irritability.
(10)
 
         In   General pain in Migraine is Unilateral, Pulsating, Fronto temporal in  
distribution   usually  accompanied by  anorexia , Nausea and vomiting.   
 Patients are intolerant to 
 Light ( photophobia) 
 Sound ( phonophobia )  
 Odours ( osmophobia )(2) 
In Children Migraine is characterized by episodic abdominal pain, motion 
sickness and sleep disturbances.
(2) 
2. CLASSIC MIGRAINE: 
          Migraine   with Aura is seen in only about 15 to 25% of cases. Migraine auras are 
focal   Neurologic symptoms that precede, accompany or follow an attack. Aura usually 
evolves over 15 – 20 mins   lasts less than 60 mins and   involves visual, sensorimotor, 
language or brainstem disturbances.
(2)
 
Aura   symptoms present as  
1. FORTIFICATION SPECTRA: 
             In the Early phase, there is isolated Paracentral Scotomas which slowly expands 
in to C shape scotoma. It appears colored   as   the scotoma moves towards the periphery 
of the involved half of the visual field then gradually it disappears over the horizon of the 
peripheral vision. This process occurs for 20 – 25 mins. This phenomenon called   
Fortification Spectra, is due to cerebral structural anomaly.
(9,10)
 
2. Positive visual symptoms such as  Shimmering ( wavy lines ) , tiechopsia and 
metemorphopsia – distortion of form ,size ,position of objects  or environment in part 
of visual field.
(13)
 
3. Positive sensory symptoms like  tingling and dysphasia or aphasia.(13) 
 4. Weakness, confusion, dysphagia, tinnitus and hemiparesis. 
             Headache may begin before or simultaneously with aura.
(10)
 There is an 
association between Migraine especially with Aura  and development of Stroke. Migraine 
is an independent risk factor for stroke. The mechanism involved in developing stroke is 
Hyperaggregability of the platelet and reduction in the cerebral blood flow in Migraine 
with aura.   
Thus, patients with Migraine are found to develop stroke with increased motor deficit on 
the basis of Rankin Disability scale which was found to be significantly worse in 
Migraine patients. 
2. COMPLICATED MIGRAINE :  
          This term refers to Migraine attacks with major neurologic dysfunction i.e., 
Migraine with hemiplegia or coma which is different from an attack of Aura. In these 
patients neurologic dysfunction outlasts the headache by hours to 1 or 2 days. Structural 
brain disease should be ruled out.
(2)
 
3. HEMIPLEGIC MIGRAINE :  
           Hemiplegic Migraine is a rare Autosomal dominant disorder , mutation in a gene 
for P/Q type calcium channel located in chromosome 19 is characterized by  hemiparesis  
during the prodromal phase of Migraine  which resolves in 20 to 30 mins then 
contralateral headache begins.
(10) 
A serious form appears as hemiplegia, affecting same 
side,  that   persists for days to weeks after head pain subsides. 
          Dysarthria and aphasia   present   in 50% of   patients. Hemihypesthesia is present 
in all cases. CSF   analysis shows pleocytosis and elevated CSF protein concentration.
(9) 
 
 4. BASILAR MIGRAINE:     
        The incidence of Basilar Migraine is common in Children in whom   severe episodic 
headache is preceded by signs of bilateral occipital lobe, brainstem or cerebellar 
dysfunction like diplopia, ataxia, vertigo and dysarthria. Bilateral sensory and motor 
disturbances can occur. 
(2)
The episodes begin with total blindness which is accompanied 
or followed by other symptoms. Symptoms persist for 30mins then followed by occipital 
headache. Sensorial alterations like confusional states will be present for 5 days which 
may be mistaken for psychotic reactions.
(9)
 
5. FACIOPLEGIC MIGRAINE:     
          Facioplegic   migraine also called Lower half headache or Facial Migraine pain   is 
restricted to nose, cheek, gums and teeth on one side of the face. Sometimes transient 
facial palsy  seen. Episodic throbbing Pain often turning into sharp, continuous, deep and 
dull aching type that last for minutes to hours is characteristic of Facioplegic Migraine. 
Tenderness and pulsations over the carotid artery and swelling of the soft tissues over the 
carotid are present on the side of the pain.
(9,12)
 
6. OPHTHALMOPLEGIC MIGRAINE:                                                                                       
 In  Ophthalmoplegic Migraine  in  addition  to  attacks  of  headache  there  is  
unilateral third nerve  palsy  associated  with  ptosis , dilated pupil  and  diplopia. Patient 
presents   with   periorbital pain   for 1 to 4 days as the pain subsides ptosis and palsy   
occurs. This ophthalmoplegia   persist for several days to even 2 months.
(9) 
 
 7. RETINAL MIGRAINE:  
         It is a rare variant of Migraine. There is sudden transient monocular blindness   
followed by retro- orbital   headache.
(12) 
PATHOGENESIS OF MIGRAINE:  
 Migraine  can be initiated  either  by Central  mechanisms  - by afferent  
stimulation from central centers in cortex , thalamus and the hypothalamus  or  by 
peripheral afferent  stimulation via Trigeminal  nerve or C1 – C3  nerve roots. Local 
defects  in the  Endogenous  pain control system prevents inhibition  of pain  stimulation 
in the spinal  nucleus of  Trigeminal  nerve.  
       Mechanism of  Migraine  can be divided into  three  phases: Brainstem  generation  is 
the first phase ; the second phase is Vasomotor activation  in which arteries  within and 
outside the brain contract or dilate ; Third phase is the Activation of the cells of the 
Trigeminal nucleus caudalis which release  vasoactive  neuropeptides at the terminations  
of Trigeminal nerve   on  blood vessels  resulting  in  soft tissue swelling and tenderness 
of blood vessels  during Migraine attacks.
(9) 
CONCEPT OF NERVE STORMS:   
            In 1873, Liveing published the concept of Nerve Storms. According  to him the 
clinically apparent circulatory  phenomena of  Migrainous  attacks  were caused by  
repeated cerebral  discharges  or  Nerve storms.
(9) 
VASCULAR HYPOTHESIS OF MIGRAINE:     
             In 1930, Graham & Wolff put forward this hypothesis, they proposed that the 
  headache  phase  of  Migraine attacks  was caused  by  extracranial  vasodilatation and  
that   Neurologic  symptoms  are  produced by  intracranial vasoconstriction.
(9)
 
 The basis for pain in Migraine is the   activation   of trigeminal vascular   system. 
First   division  of Trigeminal nerve innervating  the  large    intracranial  vessels and the 
dura  forms the  Trigeminal  vascular  system.
(13) 
TRIGEMINALVACULAR SYSTEM (TVS): 
         The TVS   arises from the dense plexus of Nociceptors, that innervate the cranial 
vasculature and the duramater. The central projections from these plexus   travel via the 
trigeminal ganglion which synapse on second order neurons in the dorsal horn that form 
Trigeminal Cervical Complex (TCC) 
(14) 
which is illustrated in Fig 1.  
         Activation of these sensory afferents releases neuropeptides that act on 
cerebrovasculature and the spinalcord. The TCC has ascending connections with 
brainstem areas like Locus coeruleus and Periaqueductal grey, thalamus and the 
hypothalamus through there ascending tracts. In addition to these the projections are 
connected to parasympathetic system via superior salivatory nucleus and sphenopalatine 
ganglion. Activation of this system causes neuronal activation in pontine and brainstem 
regions.
(10)
 
TRIGEMINAL VASCULAR REFLEX:
(10)
 
   Parasympathetic dilation of Internal & External carotid arteries 
                           ↓   
 Stimulation   of   pain centers in spinal nucleus of Trigeminal nerve. 
                   
   Activation of cells in the Trigeminal   nucleus releases   vasoactive  neuropeptides  like  
CGRP , Neurokinin A , substance P and 5-HT serotonin that causes painful meningeal 
inflammation and vasodilation. These neuropeptides also activates serotonin receptors 
and nerve endings on small dural arteries, resulting in neurogenic inflammation. These 
processes in turn stimulate perivascular nerve endings, with resultant orthodromic 
stimulation of the trigeminal nerve and pain is referred   to its distribution.
(2) 
  
     
 
 
 
 
 
 
Fig .1 TRIGEMINAL CERVICAL  COMPLEX 
 
 CORTICAL SPREADING DEPRESSION THEORY: 
The pathophysiology of Aura in Migraine can be explained by cortical spreading   
theory of Leao. According   to   this   theory, the underlying mechanism for aura is the 
disturbance of the cerebral cortex.
(15)
 
             CSD  is a  short  lasting  depolarization  wave  that   moves   across the  cortex  at  
a  rate  of   3-5 mm /min. A brief  phase  of  excitation heralds  the  reaction  which   is  
immediately followed  by  prolonged  nerve  cell  depression. Aura  represents  a  
spreading  front of  electrical  excitation  followed  by  depression  of  activity  of the  
cortical  cells. Thus, CSD  is  a wave  of  neuronal   depolarization  followed  by  
depressed   activity  spreading  slowly   anteriorly  across the  cerebral cortex from the  
occipital  cortex 
(14,15) 
as shown in the figure no.2.  
         In CSD there is change in the local pathway, cellular environment that produces 
subtle functional changes in neural performance. Precortical deficits in Migraine group 
are due to changes in ocular vasoregulation, that results in functional abnormalities either 
due to hypoperfusion or changes in local cellular environment. 
         During  attacks  of  Classic Migraine , studies  of  regional cerebral  blood flow  
showed  cortical  hypoperfusion  which averaged 25 to 30%  and  progresses  anteriorly 
in a wave like fashion . This  hypoperfusion  persists  for  4 to 6 hrs does  not  cross the  
central  sulcus  and  progresses  to the frontal lobe  via  insula. Perfusion in the 
subcortical region was found to be normal. In few patients focal ischemia was   sufficient   
to cause symptoms.
(9)
  
         In  attacks  of  common Migraine , there is  no  abnormalities  in  the  regional  
cerebral  blood  flow . So, these changes  in the blood flow  are  due  to  alterations  in  
the  cerebral  neuronal   function . Brainstem   acts as a Generator for these cortical   
events.
(9)
 
ROLE OF POTASSIUM: 
       Potassium plays a central role for CSD that any disturbance in K
+ 
homeostasis   
predispose the brain to CSD.  In the Brain  K
+
  homeostasis  or clearance  system  
depends  on  the  capacity of glial  cells . In  humans , the  lowest  glial  neuronal  cell 
ratio  is in the  primary   visual  cortex , therefore CSD  starts  in the  visual  cortex  and  
most of  the auras in Migraine are visual.
(15) 
                         
 
  
OTHER   MECHANISMS: 
            Other  systems  like  Serotonergic , Nor adrenergic and Dopaminergic  pathways; 
Hypothalamic  and  deep brainstem  structures  and  hormones  like  estrogen   are  also  
involved in the  expression  of  Migraine.  
           Thus, Migraine  can  also  occur  due to  neuronal  sensitization ,  neurogenic  
inflammation leading  to  many  neurochemical  changes.
(10) 
           There  is  dysfunction  of  neuromodulatory  structures in  the  brainstem  such  as 
Locus coeruleus, dorsal  raphe nucleus and peri aqueductal grey matter. Locus coeruleus , 
the major Nor adrenergic nucleus is activated during the acute attack  of  Migraine. Locus 
coeruleus   dysfunction lead to distractibility and   anxiety in Migraine patients.
(4) 
                            
 
 
 
 
 
                                                
 
  
 
 
 
 
 
 
 
 
 
                               Fig 2     CORTICAL SPREADING DEPRESSION 
 
1. Cortical spreading depression 
2. Release of neuropeptides 
3. Activation of brainstem 
4. Perception of pain. 
                    
 
 
          
     Electrical stimulation near dorsal raphe nucleus provoke Migraine. Projections from 
these  nucleus terminate on the cerebral arteries and alter cerebral blood flow. The Dorsal 
raphe also projects to the neurons in the lateral geniculate body, superior   colliculus , 
retina and  visual cortex. This explains the anatomical and physiological basis of   
circulatory and visual characteristics of Migraine. In addition to this the dorsal raphe 
nucleus stops firing during sleep so sleep ameliorates Migraine.
(9) 
Dysfunction of 
brainstem not only account for somatosensory component of Migraine but also for the 
auditory , olfactory and visual components.
(10) 
X – Y IMBALANCE IN MIGRAINE:   
                    There are two parallel visual pathways, Contrast   processing – X system and 
Luminance Processing Y system. In Migraine patients there is an imbalance between 
these two pathways with predominance of Luminance processing Y system. X - system 
receives input mainly from the foveal and perifoveal areas via parvocellular pathway 
whereas Y – system receives from the retinal periphery via magnocellular pathway .(16) 
                  Abnormality of these two pathways is due to impairment of GABAergic 
inhibitory interneurons or Dopaminergic transmission. Rieke Oelkers et.al using Pattern 
reversal VEP, proposed that the P1 component is attributed   by the X- system and the N2 
component by the Y – system. In   Migraine   patients, there is prolongation of N2 latency 
which is due to imbalance between these two pathways which play a role in Migraine 
pathophysiology.
(17)
 
                Interictal Y predominance increases the sensitivity to visual stimuli in Migraine 
patients. This imbalance also plays a role in habituation behavior i.e. defective 
habituation   in Migraine patients during long periods of pattern reversal stimulation.
(18)
  
MIGRAINE AND COGNITIVE FUNCTION:   
              Migraine was found to be associated with cognitive impairment which was 
demonstrated   on tests of perception, psychomotor ability, attention and verbal memory. 
Mini Mental State Examination :( MMSE) 
       There is significant difference between patients and controls as regards MMSE. 
Controls perform better than the Migraine patients. This was explained due to cumulative 
effects of Migraine attacks which result in subtle CNS dysfunction that occur due to 
repeated vascular insult.
(7)
 
COGNITIVE RESERVE THEORY:  
         This theory states that brain injury or damage result in cognitive deficit, after a 
certain threshold of damage has been achieved. Thus, cognitive deficits are more 
apparent   after a long history of   Migraine.
(7) 
             Event related potential (ERP) Component P300 was considered as a cognitive 
Neuro -electrical indicator of CNS activity. They reported longer P300 latency and lower 
P300 amplitude which suggests that Migraine is a central disorder, which has deficit in 
attention or memory.
(7)
 
           In another  study by Karen E.Waldie et.al. proposed that  there is cognitive 
impairment specific to Migraineurs but from Early age .So, they suggest that Migraine is 
 associated with  Atypical  Neurodevelopment in utero or in infancy.
(19)
 Thus , Migraine 
children  have poor Academic performance and generalized impairment in attention. 
DIAGNOSTIC CRITERIA :
(10) 
            Based on International Headache Society Classification, Migraine can be 
diagnosed   as: 
Criteria for Migraine without Aura( Common Migraine) 
A. Atleast 5 attacks lasting 5- 72 hrs 
 
B. Headache  has  atleast two of the following characteristics  , 
 Unilateral  location  
 Pulsating quality  
 Moderate or severe intensity  
 Aggravation by routine physical activity 
C. Atleast one of the following during headache : 
 Nausea or vomiting  
 Photophobia  
 Phonophobia 
CRITERIA FOR MIGRAINE WITH AURA (CLASSIC MIGRAINE ): 
A. Atleast two attacks  
B. Aura must exhibit atleast three of the following  characteristics: 
      Fully reversible and indicative of focal cerebral, cortical or brainstem dysfunction  
  Gradual onset  
 Lasts less than  60 mins 
 Followed by headache with a free interval of less than 1 hour 
 Headache may begin before or simultaneously with the aura. 
MIDAS (Migraine Disability Assessment Score)
(20)
 
                 MIDAS is used to assess the extent of patient„s   severity and disability. 
                                           MIDAS QUESTIONNARIE 
       INSTRUCTIONS: Please answer the following questions about ALL headaches  
you   had  over  the last  3 months. Write zero if you did not do the activity in the last 3 
months. 
1. On how many days in the last 3 months did you miss work or school because of 
your headache?_____________ days 
2.  How many days in the 3 months was your productivity at work or school reduced 
by half or more because of your headache ?_______________days 
3.  On how many days in the 3 months did you not do household work because of 
your headache? _______________days 
4. How many days in the 3 months was your productivity  in household work 
reduced by half or more because of your headache ?_______________days  
5. On how many days in the 3 months did you miss family, social or leisure 
activities because of your headache? ____________days. 
 
 A. On how many days in the 3 months did you  have a headache ?________days 
B.  On a scale of 0 – 10, on average how painful were these 
headaches?___________. 
Migraine Disability Assesment Score
(2)
 
          Grade I – Minimal or No disability:0- 5 
          Grade II - Mild or Infrequent disability : 6 – 10 
          Grade III – Moderate disability : 11- 20 
          Grade IV – Severe disability : >2 
GENERAL EXAMINATION:  
                  General Examination of the subjects including the vital parameters like Pulse 
rate, respiratory rate, blood pressure have been done. In addition to this Visual acuity, 
Examination of Eye, Ear, Nose and Paranasal Sinuses are carried out.  
NEUROLOGICAL EXAMINATION: 
                    Neurological Examination performed in the subjects to rule out the 
secondary   causes for headache. 
  ELECTROPHYSIOLOGICAL STUDY: 
   EVOKED POTENTIAL: 
                   Evoked potential studies are actually an extension of neurological   
Examination. Evoked potentials  are electrical signals  generated by the  nervous system  
in response to  visual, Auditory, tactile or any other peripheral  stimuli.
(21)
These studies 
 reveal  the existence  and location of neurological lesions. A slow in conduction   reflects   
inflammation or demyelination in the respective pathway. Evoked potential studies also   
detect clinically silent lesions. These studies like EEG are tests of function and are not 
Etiologically specific.
(22,23)
  
               Visual evoked potential, Brainstem auditory evoked potential and 
somatosensory evoked potentials belong to afferent evoked potentials whereas Motor 
evoked responses to electrical or magnetic stimulation reflect   multiple synapses between 
cortex and peripheral muscle are efferent evoked potentials. 
(23)
 
                Neurophysiological studies can also be used to assess the integrity of reflex 
functions and their central connections. Thus, Evoked potential techniques are non- 
invasive have better resolution,  that permits to study the functional changes in the CNS. 
VISUAL EVOKED POTENTIAL (VEP): 
                  Visual Evoked Potential   are electrical potential   differences   recorded   from 
scalp in response   to visual stimuli. VEPs  are the summed  electrical signals generated  
by Occipital areas 17 , 18 and 19 in response to visual stimulation.
(24)
 VEPs  depend on 
the functional integrity  of the central vision at any level  of the Visual pathway , so it 
assess the integrity of the entire visual system.
(25)
 
Physiological Basis of VEPs: 
          Retinal ganglion cells classified into X, Y & W cells.  X cells are small cells that 
mediate the colour vision i.e., the cone function. They have small receptive field 
 concentrated in the central retina (central visual field). X ganglion cells provide substrate 
for pattern VEPs and exhibit lateral inhibition via geniculate pathway.  
         Y ganglion cells are large mediate rod function. They have large receptive field and 
concentrated in the peripheral retina. These cells provide substrate for Flash VEPs via 
extra geniculate pathway. Activities from the peripheral retina   reach the deeper regions 
of the visual cortex   whereas stimulation from the central vision reach the surface of the 
occipital cortex. 
         VEPs are elicited by a temporal change in the Visual stimulation. Three types of 
stimuli are used to record VEP: 
1. Luminance (Light ) Flashes  
2. Pattern Onset / Offset 
3. Pattern Contrast Reversal (23) 
TRANSIENT LUMINANCE FLASH VEPs: 
        Flash VEPs are recorded in response to a strobe light or a flashing light - emitting 
diode (LED) Display or goggles. Recent studies suggest that flash VEPs primarily reflect 
the activity of striate and extrastriate cortex.
(26)
 They are elicited by a brief  flash that 
subtends a visual  field  of atleast  20 degree  in a dim illuminated room . Flash VEPs are 
more variable than the Pattern reversal VEP.
(25)
 
         Thus Flash VEPs are recommended only in patients with dense media opacities, 
poor visual acuity, poor fixation. Infants are usually tested with Flash VEP.
(27) 
 
 PATTERN ONSET/OFFSET:         
            In Pattern Onset / Offset, the checkerboard pattern is exchanged with a diffuse 
gray background. The luminance of diffuse background and the checkerboard pattern 
must be equal.
(21)
Pattern Onset / Offset VEPs show greater inter-subject variability than 
the Pattern reversal VEP. This stimulus pattern is effective for the detection of 
Malingering and for evaluation of patients with Nystagmus.
(25)
 
PATTERN REVERSAL VEP:  
          Pattern Reversal VEP is the most sensitive and reliable method of recording VEP.   
The stimulus is change of Black squares to white and white squares to black repeatedly at 
a specified number of reversals per second. VEP is generated by Foveal and Parafoveal   
components. Monocular full-field stimulation is used. 
(22)
  PRVEP is less variable than 
the pattern onset /offset and flash VEPs.
(26)
 
WAVEFORM OF VEP: 
       The Waveform consists of N75, P100 and N145 peaks. The peaks are designated as 
Negative and Positive followed by the mean peak time.P100 waveform is generated in 
the occipital cortex due to activation of primary visual cortex and thalamocortical fibre   
discharge. N145 reflects the activity of the visual association areas 18 and 19.  N75- P100 
peak to peak amplitude and P100 amplitude are measured. The mean luminance of the 
pattern should remain constant throughout the contrast reversals. 
(28) 
        
        Waveform of VEP depends upon the temporal frequency of the stimulus. At rapid 
rates of stimulation i.e., when the light flashes or pattern reversals are repeated frequently 
 at regular intervals (at 10 Hz or higher) a simpler waveform is obtained. This is called 
Steady state response. 
         If the light flash, pattern onset /offset or contrast reversals occurs infrequently (at 1 
Hz or less) the entire waveform is obtained. This is called a Transient Response.
(23) 
 MULTIFOCAL VEPs:   
         Multifocal VEP measurement is a new technique to evaluate the visual function. 
Here , VEPs are measured simultaneously from many areas of the visual field .The  
patient is instructed to view a display containing about 60 sectors each sector with a 
checker board pattern. These VEPs are used to assess disease progression in optic neuritis 
and multiple sclerosis and to exclude Non – organic visual loss. Multifocal VEPs 
compared with Multifocal ERG to differentiate diseases of retina from disease of 
ganglion cell and optic nerve.  
Factors affecting VEP: 
(24) 
            Factors that affect VEP are: 
1. Age : 
   Amplitude of the VEP is stable in adult life. In the first decade, the amplitude is 
larger and the mean amplitude is double the adult value. These changes are due to 
age related   changes in both retina and in the visual pathway. 
2. Gender : 
  P100 latency is longer in adult males than the females. This is due to longer 
   head size and  low body temperature in males. P100 amplitude is greater in           
females than in males. These changes are thought to have a hormonal influence. 
3. Eye dominance : 
   The P100 wave in the dominant eye is shorter and the amplitude is greater than 
in the Non dominant eye. The amplitude is greater in Right hemifield stimulation 
in Right handed persons. This is due to neuroanatomic asymmetries in the striate 
cortex.  
4. Eye movement : 
      Eye movement reduces the P100 amplitude. Latency is not affected by eye 
movement. 
5. Visual acuity: The VEP amplitude reduces with reduction in visual acuity. 
Latency of P100 wave was found to be normal. 
 
6. Drugs :  
  Drugs that cause constriction of the pupil increases the latency of P100 wave 
whereas   mydriatics  decreases   the latency. 
CLINICAL APPLICATION OF VEP
(22) 
         VEPs are used in the clinical assessment of 
 Demyelinating disease like Multiple sclerosis 
 Ischemic optic neuritis  
 Spinocerebellar degenerations 
 Nutritional and toxic amblyopias 
 Optic nerve tumours. 
               VEPs are used to assess the integrity or maturation of the visual pathway in 
premature infants and preverbal children. Thus, VEPs are most sensitive in diagnosing 
Optic nerve lesions anterior to the optic chiasm but also detect Retro-chiasmatic or   
postchiasmatic abnormalities. 
AUDITORY EVOKED POTENTIAL: 
         Auditory evoked potentials are signals produced in the Auditory nerve and the 
Brainstem after acoustic stimulus. It was Jeweet and colleagues who correctly described 
the sequence of ABR waveform components.
(29)
 
     Auditory evoked potentials can be divided into  
1. Short latency component 
2. Middle latency AEPs 
3. Long latency AEPs 
SHORT LATENCY AEPs:   
            These are series of Neurogenic potentials recorded within 10ms after the stimuli is 
provided. Short latency AEPs are commonly called Brainstem Auditory Evoked Potential   
or Far field electrococleography.
(30)
 
             Relatively easy to record and the waveforms and latencies are not highly variable   
among subjects. BAEP are unaffected by subject„s degree of attention and identical in 
both waking and sleep state.
(30)
 
 MIDDLE LATENCY RESPONSE: Middle latency AEPs are recorded within 80 to 
100ms and the peak latencies range from 12 to 65ms .Generators of this response are 
 located in the thalamus and Auditory cortex. Middle latency AEPs depends on the 
attention and arousal of the subject.
(30)
 
LONG LATENCY RESPONSE: 
       These responses are generated by Postsynaptic potentials within areas of cerebral   
cortex. They are used as probes for cognitive process. Long latency AEPs are used 
especially in patients who are uncooperative and in legal cases where Non-organic loss 
should be excluded.
(29) 
BRAINSTEM AUDITORY EVOKED POTENTIAL (BAEP):  
      BAEPs are the potentials recorded from the Ear and scalp in response to a brief 
auditory stimuli that asses the conduction through the auditory pathway from the auditory 
nerve up to Midbrain.
(31)
 Transduction  of acoustic stimulus by the ear cells create an 
electrical signal that appear as evoked potential and is carried through the auditory  
pathway to the brainstem and from there to the cerebral cortex. 
(32)
  
      BAEPs are recorded within 10ms after the acoustic stimulus. Stimulus is delivered to 
one ear via headphones while the contralateral ear is masked with continuous white noise 
at an intensity of 30 to 40db which is below that of the BAEP stimulus.
(28)
 
     The stimulus is usually a square wave pulse. If the electrical square pulse causes the 
diaphragm of the earphone to move toward the patient„s ear then condensation click is 
produced.  Reversing the polarity produces a  rarefaction click .The amplitude of the 
waveforms are affected by the type of the stimulus. 
(30)
 
 
 WAVES OF BAEP: 
       Five to seven waveforms are recorded within 10ms of auditory stimulus. Wave I 
originates  from  the peripheral  portion of the eighth cranial nerve adjacent to the 
cochlea,   Wave  II arises from cochlear nucleus, Wave III  from superior olivary  
nucleus, Wave IV  originates from  the lateral lemniscus and Wave V from inferior 
colliculi. 
(32) 
           Wave I is the first prominent upgoing peak in the ipsilateral ear recording channel. 
It is reduced or absent from the contralateral ear recording channel where as Wave II is 
more prominent in the contralateral channel recording. Wave III is the prominent upgoing 
peak, Wave IV is a small wave, sometimes it may be absent or appear as a bifid wave 
along with Wave V which is the most prominent wave in the recording of BAEP. 
(32) 
Interpeak latencies: 
(28 )
     
        The interpeak latencies measured are I-III, III- V & I- V.  They are measured as the 
distance between the peaks of both waves.  
        I - V IPL measures conduction from the proximal part of 8
th
 cranial nerve up to the 
Midbrain. Normal value is 4ms. Prolonged in conditions like demyelination and 
degenerative diseases. I-III IPL represents conduction from the eighth nerve into the 
core of the lower pons. Normal value is 2.5ms. prolonged in conditions like tumours of 
the eighth nerve and at pontomedullary junction. III - V IPL represents conduction from 
the lower pons to the midbrain. Normal range is 1.9 – 2.4ms. 
 
 Factors affecting BAEP: 
(31)
 
             Factors that affect BAEP are: 
1. AGE:   Age has an distinct effect on BAEP Waveform latency . Till the age of 
18months BAEP is age dependent. Older adults have slightly prolonged I-V IPL 
than the younger individuals. 
2. GENDER : 
    Females have shorter latency and larger amplitude than males. It is due to 
higher core body temperature and shorter length of the brainstem auditory 
pathway. 
3. BAEP waveforms are resistant to the effect of   various Drugs. 
CLINICAL APPLICATIONS OF AUDITORY EVOKED POTENTIAL: 
(28,33)
 
 Used to assess conduction through the auditory pathway up to midbrain. 
 To assess severity of hearing deficits. 
 To assess functioning of middle portion of brainstem and localization of 
brainstem dysfunction. 
 Identification and quantification of hearing loss in children who are 
uncooperative for audiometry. 
 Used for intra operative monitoring of auditory nerve. 
              Other findings in evoked potentials are cortical evoked potential and nociceptive 
blink reflex in Migraine patients with and without aura demonstrate lack of habituation   
during repeated stimulation due to CNS dysfunction.
(34) 
 FINDINGS OF EVOKED POTENTIALS IN MIGRAINE PATIENTS:
 
VISUAL EVOKED POTENTIAL: 
         EL- Shater et al.,
(35)
  
                  Studied, PRVEP in 30 Migraine patients (11 patients with aura & 19 patients 
without aura) P100 latency was significantly   prolonged in Migraine with aura cases not 
in without aura patients when compared with controls. There is no significant difference 
in P100 amplitude between patients and controls. They demonstrated that there is subtle 
neuronal damage within the visual system of migraine patients especially in patients with 
aura. This may be due to recurrent cerebral hypoperfusion and due to cortical 
hyperexcitability between attacks. 
     Laila EL Mosly et al.,
(7) 
  
             Evaluated  the effect of Migraine  on quality of life in females and associated 
changes in evoked potentials . They recorded VEP in 30 Migrainous females and reported 
that   P100 latency was prolonged in Migraine patients but there was no significant 
difference in P100 amplitude. The prolongation was due to occipital cortex dysfunction 
that plays a role in the pathogenesis   of   Migraine and found to have a structural basis. 
  Pedro.F.Moreira  Filho , Adalmir M.Dantas 
(36)
  
       Studied PRVEP in 27 Migraine patients without  aura. The study   revealed that there 
is a significant increase in the latency of P100 wave when compared with controls. On 
this basis they concluded that VEP–PR can be used for investigation in Migraine patients 
without aura. 
   
 Bockowski.L et al., 
(37)  
       
Measured VEP in  51 children , 12 with aura and 30 patients without  aura  and 9 with 
other variants of Migraine .They  showed that P100 latency  was significantly prolonged 
than  in the controls and Amplitudes  N1 – P100 and P100 – N2 were significantly larger. 
These abnormalities were related to cortical spreading depression and due to alterations 
in the central neurotransmission. 
   N.Ashjazadeh . B.Varavipour 
(38) 
  
      Done VEP in 53 Migraine cases (27 with aura, 26 are with common Migraine). They 
demonstrated that only in patients with classic Migraine P100 latency was significantly 
prolonged when compared with controls whereas there is no significant difference in 
P100 – N140 peak to peak amplitude between patients and controls reported it to be due 
to hyper excitability of the brain and due to synaptic delay. 
      Nofal M Khalil , Nigel J Legg ,Duncan J Anderson 
(6)  
        
 Studied PRVEP in 92 Migraine patients. The mean latency of P100 wave was 
increased significantly in both Migraine with aura and without aura patients. P100 
amplitude was increased by 23 % in both Migraine with aura and without aura patients of 
short duration while it was decreased by 21% for a duration of 30yrs or more. This   
decline is due to subtle neuronal damage in the visual system from repeated transient 
ischemia. 
 
  
 Akbar Hamzei Moghaddam et al.,
(8)  
 
      Recorded VEP in 30 classic Migraine patients and revealed that there was   reduction   
in the amplitude of P100 and increase in P100 latency during an attack   as well as after 
aura. This reduction in amplitude is due to spreading depression wave and that hypo 
perfusion wave is continued for 4- 6 hrs after an aura. So it persists after an attack also. 
  Boylu E et al., 
(39)
  
Studied VEP in 41 Migraine patients and reported that the latencies of N75, P100 and 
N145 were significantly prolonged than the controls whereas the N75 – P100 peak to 
peak amplitude in the study group were lower when compared with controls. So, they 
suggest that there is persisting dysfunction of pre cortical visual processing which may be 
relevant in understanding the pathogenesis of Migraine. 
  Kennard et al.,
(40)
  
Studied VEP in Migraine patients and reported longer P100 latency in Migraine patients 
with aura. They suggested that prolonged latency have a structural basis due to ischemic 
damage from repeated attacks. Hyperexcitability of the brain is the cause for changes in 
P100 latency. 
   Khalil et al.,
(41)
  
Reported that there is prolonged P100 latency but the study suggested that prolonged 
latencies are constitutional, perhaps due to synaptic delay.  
  
Bramanti et al .,
(42)
   
      Studied  about positive correlation of prolonged latency with disease duration and 
frequency of the attack in Migraine patients. The study reported that P100 latency altered 
significantly in patients with numerous attacks and longer duration of Migraine, they 
suggested that prolongation is due to ischemic damage from repeated attacks. 
  Polich  et al., & Schoenen  et al .,
(43)
 
 Reported that the alteration of P100 latency in Migraine patients was found mainly in 
Migraine patients with aura and it was significantly correlated with prolonged aura.  
   Golla & Winter
(44)
  
       Was the first to reveal the changes in VEP to repetitive flash stimulus in Migraine   
patients. They demonstrated VEP in 113 Migraine without aura cases and found   
significant difference between patients and controls. 
     Richey et al.,
(45)
   
Measured VEP in 50 patients (29 without aura  & 21 with aura). They reported that there 
is no alteration in the latencies and amplitude was decreased in Migraine patients.  
     Lehtonen et al., 
(46)
  
Studied, VEP to flash stimuli in 33 patients (19 without aura, 14 with aura) they reported 
that latencies were greater in Migraine patients than the control group. 
  
Mariati et al .,
(47)  
    Obtained  VEP - PR in 20 Migraine patients with visual aura and without aura. They 
observed an increase in the P100 latency in Migraine patients where as amplitude results 
are quite dispersed among patients and controls. They suggested that alterations in the 
monoamine neuromediators occur during the interictal period. 
 Benna  P et al ., 
(48) 
 
 Measured VEP in Migraine petients .VEP parameters are normal in Migraine patients 
when compared with the patients with Vertebro basilar TIA. Thus, PRVEPs are useful in 
evaluating the damage caused by any noxa, but it cannot clearly emphasize factors 
predisposing to specific pathology. 
  Drake ME et al ., 
(49)
  
 Recorded  VEP in 50 patients with common Migraine. The waves N1, P1 and N2 
latencies were longer in Migraine patients than in controls and VEP amplitudes were 
minimally greater. No significant   differences   were found between patients and 
controls. 
BRAINSTEM AUDITORY EVOKED POTENTIAL: 
  D Kaushal , S Sanjay Munjal , M Modi , N Panda 
(50)
 
          Evaluated BAEPs in  25 Migraine patients. They reported prolongation of latencies 
of Waves I, III & V and I-III & I- V interpeak latencies. These findings suggest 
 involvement of Brainstem structures as well as activation of brainstem in Migraine 
patients. 
 Firat Y et al ., 
(51)
  
            Measured  auditory brainstem responses in pediatric population during the period 
of an attack and asymptomatic period of Migraine. There is prolongation of wave V and   
I –V   Interpeak latency during the attack in Migraineurs. This   indicate that there is a 
transient impairment of   auditory  brainstem function in Migraine patients. 
  Schlake HP et al ., 
(52)
   
          Reported that in Migraine patients the peak latencies are pathologically delayed   
but there was no significant difference between patients and controls. However   side 
differences of all the peaks were significantly increased in Migraine patients than the 
controls. These results indicate that there is permanent impairment in the brainstem   
function in Migraine patients. 
  Anil K Dash et al ., 
(53)  
          Studied audiovestibular functions in cases of Migraine patients with and without   
vertigo. BAEP  revealed that  there is  significant  prolongation  of latencies  of  wave  I, 
wave III & V  and interpeak latencies I- III , III-V & I- V. The study concluded that 
BAEP abnormalities are the earliest indicator of impending auditory involvement in 
patients with Migraine. 
  Laila EL Mosly et al., 
(7)
  Evaluated the effect of Migraine on quality of life in females 
and associated changes in evoked potentials. They measured BAEP in 30 Migraine 
 patients and reported   that there was prolongation of wave III & wave V latency and I- 
III and I- V interpeak  latency  but no significant change in III – V interpeak latency   
both during an attack  and in the interictal  phase. 
   Bayazit Y et al .,
 (54)  
         Studied BAEP in Migraine patients , they reported abnormal BAEP findings  with  
increased  latency of waves I , III & V  and the interpeak latency  III-V. 
  Yang Y ,Li P , Ye HC 
(55)  
        Explored  personality  test and BAEPs in 30 Migraine patients. They   reported  that 
the latencies of wave I , III & V and the  Interpeak latencies of III- V are prolonged and   
related this prolongation  to brainstem dysfunction. 
      Zgorzalewicz M  et al ., 
(56)
  
The study evaluated BAEP in children with primary headaches. They reported significant 
prolongation of latencies of wave III & IV in Migraine children when compared with 
TTH. This study suggests that brainstem contributes to the pathophysiology of Migraine. 
     Sherifa A Hamed , Amal Mohammed Elatter 
(57)
  
            Evaluated vestibular function in 58 Migraine patients and reported prolonged 
latency of wave III and I-III, III -V& I - V interpeak  latencies. This study suggests that   
in cases chronic Migraine, there is permanent vestibular damage either peripheral or 
central vestibular pathways. 
 
  Drake  ME et al ., 
(49)
  
In this study BAEP was measured in 50 common Migraine cases. They found that there 
was significant  prolongation  of   I – V and  III - V interpeak latency in  Migraine 
patients. This study suggests dysfunction of brainstem centers possibly related to 
endorphin or serotonin   neurotransmission. 
Benna et al ., 
(48) 
      
Studied BAEP in 20 Migraine patients in which they reported no alterations in BAEP 
Parameters in Migraine Patients. 
HABITUATION IN MIGRAINE: 
(24) 
            It   has been reported that PRVEP recording in Migraine patients, based on 
periods of stimulation, the normal habituation pattern was found to be replaced by 
potentiation in the Interictal period. Defective habituation was present not only for visual 
processing but also for auditory evoked responses and event related potentials.  
         This lack of Habituation depend on chemical   connections from the brainstem that 
include serotonin, dopamine, Noradrenaline, acetylcholine and histamine.These 
transmitters diffusely innervates the layer IV pyramidal cells and the interneurons in the 
sensory cortices and have regular , tonic , pacemaker activity. Low pre activation level in 
the sensory cortex and low activity in the raphe cortical serotonergic pathway causes 
increased thresholds and a supra threshold   activation before reaching a saturation or 
„ceiling effect ‟. This is responsible for the initial low amplitude waves then followed by 
high amplitude curves during   long periods of stimulation.  
         Defective habituation had a deleterious effect on metabolic homeostasis in the brain 
parenchyma. However habituation was thought to protect the cerebral cortex against   
sensory overload. 
OTHER IVESTIGATIONS:  
CT / MRI: 
(58)
 
     CT / MRI scans are often done in Migraine patients to rule out the secondary causes of 
headache. CT scan in Migraine patients especially with complicated Migraine reveal   
cerebral infarction or occlusion commonly in the Posterior cerebral artery is involved 
producing a deep Parietotemporal infarct. In some cases, Frontotemporal infarct in the 
territory of Middle cerebral artery has also been reported. The prognosis, functional 
recovery was found to be good. CT findings in other forms of Migraine are normal. 
 MRI: 
(59)
 
           MRI in Migraine patients demonstrated White matter lesions (Fig 3). Anatomical 
changes are reported in both white matter and to some extent in the gray matter also. 
These cannot be used as a reliable marker for the diagnosis of Migraine. WMLs   are not 
specific, it may be due to Ischemia, Demyelination and Connective tissue diseases. 
Significance of presence of   WMLs is that Migraine patients are more prone to develop 
Ischemic stroke especially with Deep white matter lesions (DWMLs) .  
 Pavese  et al ., studied T2 weighted MRI in Migraine patients and found that 19.3% of 
Migraneurs had DWMLs , So this study documented that  Migraine is a risk factor for 
Cerebral ischemia. 
                                       Fig . 3 DWMLs in cerebral cortex 
                        
 
 
 
 
 
 
                   Auditory aura in patients with Migraine manifest in the form of auditory   
hallucinations but the condition is very rare. A patient with auditory aura was evaluated 
with MRI and found that there was a lesion in the lateral lemniscus along the auditory 
pathway. This peduncular lesion  represent a migrainous infarct due to vasoconstriction.  
          This study revealed that either damage to the ascending reticular systems or loss of   
brainstem control of descending cortical process may be responsible for such changes in 
Migraine patients.
(60)
 
PET STUDY :
(61)
 
            PET Study in Migraine patients revealed significant brainstem activation 
particularly in the dorsal Pons and Rostral medulla. Other areas which appear activated  
               
                                             
                                         
                                       Fig 4    PET STUDY IN MIGRAINE 
 
are anterior cingulate, bilateral Insula , bilateral Cerebellar hemispheres , prefrontal 
cortex and putamen as shown in Figure 4. PET study taken following treatment with 
Sumatriptan, showed that dorsal pons remained active even after the treatment. There is 
an imbalance in activity between brainstem nuclei regulating anti nociception and 
vascular control.  
REGIONAL CEREBRAL BLOOD FLOW ( rCBF ): 
(62) 
        Cerebral blood flow falls by about 20% during attack in Migraine with aura reaching 
40 – 50 ml /100g/min. This was explained as due to reduced level of metabolic activity 
during CSD. In the least perfused areas, the flow has been decreased   to 16-23 ml / 100g 
/min. This degree of hypoperfusion, definitely produces transient hypoxia and 
neurological deficits due to damage to that area from repeated ischemia. The final 
pathway for this cell damage follows  Neurotoxicity, from the action of Excitatory 
 aminoacids  that results in neuronal damage through prolonged activation of  NMDA 
receptors.
(6)
 
              In 1980, Olesen and his coworkers used Xenon blood flow techniques to study 
the changes that occur during an aura. The study revealed that rCBF reduced mainly in 
the posterior regions of the brain, hypoperfusion was also seen in Frontal cortex. This   
decreased blood flow persisted for one hour. After one hour rCBF either normalized or 
remain decreased in the focal regions. This decrease in blood flow was not sufficient to 
cause ischemia and was termed just as spreading   oligemia. 
          rCBF was measured by using SPECT  during Migraine attacks. Patients with 
common Migraine showed normal cerebral blood flow pattern during an attack. In 
patients with classic Migraine most patients displayed unilateral hypoperfusion and few 
revealed normal perfusion. These changes are not related to distribution of cerebral 
arteries but to cerebral metabolism with increase in the lactate levels.
(59)
 Studies of 
cerebral blood flow  suggests that there are areas of focal ischemia surrounded by 
hyperemia during Migraine  attack. They also demonstrated elevated GABA and cAMP  
after  an Migraine attack which  represents cerebral ischemia occurs during an attack. 
ELECTRO NYSTAGMOGRAPHY (ENG): 
(63)
 
         ENG reveals horizontal deviations, indicating impairment of vigilance in Basilar 
type of Migraine in whom vestibule cochlear functions are impaired. In other types of 
Migraine ENG was found to be normal. 
 
  
CSF ANALYSIS IN MIGRAINE :
(64,65)
 
               CSF in Migraine patients, in classic and common Migraine reveal normal cell 
count and normal CSF pressure both during and in between attacks but the total protein 
content was lower than in the controls. The CSF 5-hydroxy indole acetic acid (5- HIAA) 
was found to be higher in Migraine patients during attacks. 5–HIAA is the end product of 
serotonin metabolism, this suggests that serotonin plays an important role in the 
pathophysiology of   Migraine.  
FUNCTIONAL NEURO IMAGING: 
(66)     
       Perfusion weighted Imaging (PWI)–Gadolinium based   fMRI technique was applied   
to study about Migraine aura. PWI is sensitive to microvascular changes, minimally 
Invasive and has higher spatial resolution than radionuclide based techniques. fMRI 
evaluates both hemodynamic changes and metabolic parameters at the same time. 
         They proposed that relative cerebral blood volume and relative cerebral blood flow   
decreased in Migraine patients on average of 35% and 19%   respectively   while the 
mean transit time was increased by 32% in the gray matter of the occipital cortex 
opposite to the affected visual hemifield. Hemodynamic changes are not seen in other 
areas like thalamus, frontal & temporal cortex or brainstem during an attack of aura.  
         Additional information was obtained from Magnetization Transfer Imaging (MTI) 
and Diffusion Tensor imaging (DTI).
(59)
 
                MTI in Migraine patients showed that the WMLs are due to ischemia with 
relative gliosis, there is no infarction. There is no significant difference between patients 
and controls using this technique.
(59) 
             DTI detect ischemic tissue with higher resolution and sensitivity than the 
conventional MRI. Here the histograms of the average mean diffusivity (D) of the normal 
appearing white matter (NAWM) Was lower in Migraine patients than the controls. This 
damage may be due to recurrent ischemia or secondary to Wallerian degeneration of 
axons projecting into NAWM from the WMLs. They also suggested that cortical 
reorganization occurs due to deep WMLs. Though, White matter lesions are most 
commonly seen anatomical changes in Migraine, it cannot be considered as a bio- marker 
for the diagnosis of Migraine.
(59)
 
Complications of Migraine: 
 Chronic Migraine  
 Status Migrainosus 
 Persistent aura without Migraine  
 Migrainous Infarction  
 Migraine triggered Seizures. 
TREATMENT: 
(2) 
                The aim in Migraine treatment is to reduce the severity, frequency and duration 
of an attack and to improve the life quality of the patient.  
   Non – pharmacologic treatment  
 Management  of Acute attack 
 Preventive therapy. 
NON –PHARMACOLOGIC TREATMENT: (10) 
          This includes   Identification and avoidance of   headache triggers, regulated   
lifestyle, stress management that includes Yoga, Meditation, Hypnosis, balanced diet and 
Biofeedback relaxation. All these measures decrease neuronal irritability and reduce the 
frequency of attacks. If these   measures fail, pharmacologic treatments are necessary. 
MANAGEMENT OF ACUTE ATTACK: 
(2,3)
 
             Acute treatment should begin as soon as possible after the onset of headache. 
Repeated use of analgesics should be avoided because it exacerbates the pain. Mode of 
treatment depends on the severity of attacks. Mild attacks need oral therapy that yields 50 
to 70% efficacy. During attacks the Gastrointestinal motility will be reduced so, drug 
absorption will be impaired. If the oral agents fail then rectal administration of 
Ergotamine, subcutaneous triptans are given. In Classic Migraine, Ergotamine is given 
either sublingually or rectally to abort the attack during the prodromal phase. Severe 
attacks require Parenteral   therapy. 
           Three major classes of drugs used are  
a. Anti inflammatory drugs 
b. 5 HT  receptor agonists  
c.  Dopamine receptor antagonists 
    
  Anti inflammatory drugs: 
                     NSAIDs reduce both severity and duration of Migraine attack. For 
effectiveness it should be taken early during an attack. A combination of Acetaminophen, 
Aspirin and Caffeine can be used for effective therapy. Major   side effects are dyspepsia 
and gastrointestinal irritation.
(3)
 
 5 HT RECEPTOR AGONISTS:
(67) 
           These drugs can be administrated via oral, nasal or parenteral depending upon the 
severity of the attack. Triptans act on 5HT1b receptors and produces constriction of 
cranial vessels, through 5HT1D receptors they inhibit peripheral trigeminal afferents that 
innervate the vessels and the duramater. Peripheral inhibition also involves inhibition of 
CGRP release thereby reducing the trigeminally mediated inflammatory process. 
ORAL ROUTE : 
          Ergotamine and Dihydroergotamine are non selective 5 HT receptor agonists. 
Triptans are selective agonists. Triptans commonly used are Sumatriptan , Naratriptan , 
Zolmitriptan and Frovatriptan . Monotherapy with triptans are not effective so, co-
administration of NSAIDs with triptans are recommended. Triptans are avoided when 
there is any vascular disease and Ergotamine group of drugs are contraindicated in 
pregnancy, hypertension, ischemic heart disease and peripheral vascular disorders. 
(3)
 
NASAL ROUTE:  
              Nasal formulations available are Dihydroergotamine and Zolmitriptan, they 
provide faster and more effective relief.  
 PARENTERAL:    
         Parenteral   administration   of   Dihydroergotamine and sumatriptan were   
approved. Following  Administration,  peak plasma levels reach by 3mins via I.V. route , 
30mins after I.M. and  45mins after subcutaneous route.
(3)
 
DOPAMINE ANTAGONISTS: 
     Dopamine antagonists are used as adjunctive in Migraine therapy. Addition of   
dopamine antagonists like Metaclopramide increase gastric absorption of other drugs 
also. Parenteral drugs like Chlorpromazine, Prochlorperazine and Metaclopramide  
provide  acute relief from  Migraine.
(13)
 CGRP  antagonists are effective in acute 
treatment eg. Telcagepant. 
OTHER MEDICATIONS: 
(3) 
        
The combination of Acetaminophen, dichloralphenazon and isometheptene can be 
given orally. Butorphanol nasal preparation can be used in selected group of persons. 
Narcotics are beneficial in acute management of pain. The main drawback is that it 
causes craving or withdrawal and can aggravate the attack. So they are limited to patients 
with severe headache not responding to other therapies. 
PREVENTIVE THERAPY: 
(3)
     
         Preventive therapy is initated in patients with increasing frequency of Migraine 
attacks or in those who are not responding to the current treatment. Drugs used are   
Amitriptyline , Propranolol , Timolol , Sodium valporate , Topiramate  and 
Methysergide. These drugs should be taken daily and have the capacity to stabilize   
 Migraine.  The probability of success with single Anti – Migraine drug is 50- 75 %. Thus, 
these drugs can alter the natural history of Migraine. 
Relaxation technique in Migraine: 
(68) 
        Lifestyle and behavior modification programmes can significantly lower the 
frequency as well as the severity of Migraine attacks. Meditation along with deep 
breathing can be used as adjuncts to routine anti Migraine treatment. 
PROGNOSIS: 
       Prognosis in Migraine patients is highly variable. Severity decreases with age, 
whereas in patients with aura without headache severity increases with age. Modification   
of trigger factors can improve the condition. In some cases Migraine can turn in to 
chronic, defined type with 15 days headache/month particularly in obesity and low socio 
economic state condition. 
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                                 MATERIALS   AND  METHODS     
                 This study, a case control study was conducted in the Research laboratory, 
Department of Physiology, Thanjavur Medical College & Hospital, Thanjavur. The study 
period extended from August 2013 to June 2014. The subjects were   recruited from the 
Out-patient   clinic of Department of Neuromedicine. The study group  comprises of 40 
Migraine patients who are subdivided  in to  16 patients – Migraine with Aura and 24 
patients – Migraine without Aura , 4 males and 36 females  of  age group 19 to 52 yrs 
were selected according to International  Headache  Society  Diagnostic  Criteria  for  
Migraine. 
            Patients   with   history suggestive of other types of headache, TTH, cluster 
headache, sinusitis   and subjects with Visual field defects, auditory deficits are excluded 
from the study.  
         Out of 40 controls, 6 males and 34 females   of age group of 19 to 55yrs with mean 
age of 35.45 ± 9.9 years with no history of  headache, healthy controls were included in 
the study. 
INCLUSION CRITERIA:  
            Patients in the age group of 19 to 52 yrs diagnosed as Migraine with   episodes of 
headache for atleast  2 yrs and  atleast  2 attacks  per month in the last quarter year  were 
included in  the study.  
 
 
 EXCLUSION CRITERIA: 
               Subjects with  
 Neurological diseases 
 Ophthalmic diseases  
 ENT  & Systemic diseases  
 Visual and Auditory deficits. 
             Ethical Committee approval was obtained from the institution before 
commencing the study. The nature of the study was explained to the subjects, an 
informed written consent was obtained from the subjects prior to the study. 
           A detailed history   of Headache duration, frequency and history suggestive of 
aura and history to rule other types of headache were noted. Ophthalmologic examination 
was done to determine visual acuity, Field of Vision, extraocular movements and   
pupillary  diameter. All patients had Visual acuity 6/6 or corrected with optical lenses and 
none had any visual disorder. 
ELECTROPHYSIOLOGICAL ASSESSMENT: 
         The following elctrophysiological parameters are studied in cases & controls. 
 Visual Evoked Potential (VEP ) 
 Brainstem Auditory Evoked Potential (BAEP )  
              All the parameters ( Latency & Amplitude ) were recorded  using Four channel 
polygraph , Digital  intex colour monitor , 17 ” model no: IT – 173 SB. 
  
Method of recording VEP: 
(32)
 
        Electrodes   are placed using 10-20 electrode placement system.  
Visual evoked potential:  
      The subjects were informed about the procedure of the VEP test and informed 
consent was obtained from the subject.  
Pre test instructions: 
(28)
 
 The subject is asked to avoid applying hair oil or spray after the last hair 
wash. 
 If the subject uses optical   lenses, glasses should be worn during the test. 
 The subject is instructed not to use any miotics or mydriatics 12hrs before 
the test. 
 The room should be quite and comfortable. 
Procedure:  
              The patternshift  Visual  evoked potential was  measured  separately for Right 
eye and Left eye . It involves the following steps: 
 The skin is prepared by abrading and degreasing before applying the 
electrodes for proper contact of electrodes. 
 
 
  
 ACTIVE ELECTRODE:  
         Placed at Oz - 10% from the inion using EEG paste as per 10-20 
international system for electrode placement. 
 REFERENCE ELECTRODE :    Reference electrode is placed at FPz  
position. 
   GROUND ELECTRODE:   Ground electrode is placed at vertex Cz as 
shown in Fig no.7. 
 The subject  is instructed or  made to sit at a distance of 1m  from the VEP 
screen. ( Zebronics  CRT  monitor  showing pattern  reversal stimuli in 
checker  board  pattern with  reversal rate  2/sec , contrast 50-80 % , check 
size 28-32 of arc and average number of trials – 100 ) 
A waveform is obtained. VEP latencies (N75, P100 & N145 in ms) are   
marked as in Fig 5. 
 
 
 
 
 
                                      
 
                                    
 
                                        RECORDING OF VEP 
                                (Instrument setting for VEP) 
  Settings VEP 
Sweep 20msec 
Sensitivity 10µv 
Low cut 2Hz 
High cut 200Hz 
Pulse 1/sec 
Pulse width 0.1msec 
Notch Off 
Recordings 
100 average was  recorded using 
checker board pattern stimulus 
 
 
 
  
Fig 5     Normal VEP Waveform 
                 
 
   
 
 
 
 
 
 
 
 
 
 
                     
    
 
 
 
 
                             
 
                     
Parameters 
 
  Mean value 
P100 latency(ms) 96.9 ±3.6 
 
Amplitude(µv) 1.5 ± 0.5 
 
Duration(ms) 55.9 ± 7.7 
 
                            Fig 6   Normal BAEP Waveform 
         
 
 
WAVEFORM 
 
GENERATORS 
 
I VIII Nerve 
                     II 
 
                        Cochlear nucleus 
                    III 
 
Superior olivary nucleus 
IV 
 
Lateral lemniscus 
V 
 
Inferior colliculi 
            
 Brainstem auditory evoked potential: 
          The subject was explained about the procedure of the test and informed consent 
was obtained. 
Pre test instructions: 
(31)  
 The subject is asked to avoid applying hair oil or spray after the last hair wash. 
 Examination of external ear and hearing tests (Rinne„s & Weber test) are 
done. 
 Room should be quite and comfortable. 
Procedure:  
           The procedure is explained to the subject. It involves the following steps.. 
 The skin is prepared by abrading and degreasing before applying the 
electrodes for proper contact. 
 Electrodes are placed according to 10 – 20 electrode placement system. 
    Channel 1 is placed at Cz - Ai ( ipsilateral ear ) 
    Channel 2 is placed at Cz - Ac ( contralateral ear )  
 Ground electrode is placed 20% from the Nasion – Fz position. 
 Auditory stimulus in the form of click sound is delivered through the 
headphones. 
     Clicks are delivered at a rate of 8-10 /sec 
      Intensity of the stimulus is set at 60db 
      About 100 averages were recorded as in Fig 8. 
                                           RECORDING OF BAEP 
                                       (Instrument setting for BAEP) 
Settings BAEP 
Sweep 5msec 
Sensitivity 10µv 
Low cut 100Hz 
High cut 10kHz 
Pulse 11/sec 
Pulse width 0.1msec 
Notch On 
Decibel 60db 
Recordings 
100 average was recorded using 
click stimulus 
 
               BAEP waveforms Wave I, II, III, IV& V are obtained as in the Fig 6. 
 Statistical Analysis: 
                Electrophysiological parameters were analysed by using statistical package 
SPSS version 20. The statistical analysis was done using unpaired student „t ʼ test. 
 
 
 VEP RECORDING 
 
            
 
               
                                                               Fig 7 
                                             
 
 BAEP RECORDING 
                     
 
                       
                                                                            Fig 8 
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                                                 RESULTS 
             The study group  comprises of 40 Migraine patients who are subdivided  in to  16 
patients – Migraine with Aura and 24 patients – Migraine without Aura , 4 males and 36 
females  of  age group 19 to 52 yrs were selected according to  International  Headache  
Society  Diagnostic  Criteria  for  Migraine. Out of 40 controls, 6 males and 34 females   
of age group of 19 to 55 yrs with mean age of 35.45 ± 9.9 years with no history of any 
headache were included in the study. 
               The mean values and their standard deviation for the control group and study 
group - Migraine patients with aura and without aura were tabulated. Various 
electrophysiological parameters in VEP and BAEP are compared between the two study 
groups and the control group. 
            The results were analysed using student t test. P value less than 0.05 was 
considered as statistically significant. 
Findings of evoked potential study in Migraine with Aura : (Table 3 )  
 Visual Evoked Potential : 
 Our study results showed that there was a significant   prolongation of P100 
and N145 Latency with P value < 0.05 whereas P100 amplitude value was 
increased in Migraine with aura patients when compared with controls but it 
was not statistically significant with P value 0.654. 
 Brainstem Auditory Evoked Potential :Study results showed a significant 
prolongation in the Latencies of wave I , III & V and the Interpeak Latencies  
I - III , III – V & I - V  ( p < 0.05 ) as compared to control group. 
 Visual Evoked Potential : (Table 4 )  
 VEP N75 Latency: The mean value of N75 in Migraine with Aura was 
found to be 71.5438± 3.41818 and in the control group it is 70.5750 ± 
4.20058 with P value 0.416 and the difference was found to be insignificant. 
  P100 Latency: P100 Latency mean value in Migraine with Aura was 
observed to be 102.0625 ± 5.70782 and in the control group it is 95.1625 ± 
3.56512 with P value 0.000 and the difference was found to be statistically 
significant. 
  N145 Latency: The mean value of N145 in Migraine with Aura was found 
to be 136.2188 ± 10.45302 and in the control group it is 129.9875±8.61460 
with P value 0.025 and   found to be statistically significant. 
 P100 Amplitude: P100 Amplitude mean value in Migraine with Aura was 
observed to be 6.2344 ± 3.28791 and in the control group it is 5.7975 ± 
3.27955 with P value 0.654 and the difference was found to be statistically 
insignificant. 
Brainstem Auditory Evoked Potential : (Table 4 ) 
              Latencies of Wave I, III & V and the Interpeak latencies I-III, III – V & I-V 
were measured. 
 WAVE I: The mean value of wave I latency in Migraine with Aura was 
observed to be 1.2725±0.29322 and in the control group 1.1222±0.22525 
with P value 0.044 and found to be statistically significant. 
  WAVE III: Wave III latency in Migraine with Aura was observed to be 
3.9381±0.62159 and in the control group 3.4323±0.63872 with P value 
0.009 and found to be statistically significant. 
 WAVE V: The mean value of wave V latency in Migraine with Aura was 
observed to be 6.3444±1.39867 and in the control group 5.6510±0.91618 
with P value 0.033 and found to be statistically significant. 
 I - III IPL: I – III Interpeak latency in Migraine with Aura was observed to 
be 2.6625±0.57633 and in the control group 2.2797±0.57041 with P value 
0.028 and found to be statistically significant. 
 III – V IPL: III – V Interpeak latency in Migraine with Aura was observed 
to be 2.5906±0.57130 and in the control group 2.2420±0.45662 with P 
value 0.020 and found to be statistically significant. 
 I – V IPL: The mean value of I-V IPL in Migraine with Aura was observed 
to be 5.2556±1.04950 and in the control group 4.4888±0.81594 with P 
value 0.005 and found to be statistically significant.  
Findings of evoked potential study in Migraine without Aura: (Table 2) 
 Visual Evoked Potential : 
            Our study results showed that there was a significant prolongation of   
P100 and N145 Latency with P value < 0.05. P100 amplitude did not differ 
significantly when compared with controls with P value 0.732. 
 Brainstem Auditory Evoked Potential:   Study results showed a significant 
prolongation in the Latencies of wave I, III & V and the Interpeak latencies  
 III – V & I - V  ( p < 0.05 ) as compared to control group. I - III IPL was not 
significantly prolonged. 
Visual Evoked Potential : (Table 5 ) 
 VEP N75 Latency: The mean value of N75 in Migraine without Aura was 
found to be   71.4896± 4.62653   and in the control group it is 70.5750 ± 
4.20058 with P value 0.420 and the difference was found to be insignificant. 
  P100 Latency: P100 Latency mean value in Migraine without Aura was 
observed to be 99.9792 ± 5.06261 and in the control group it is 95.1625 ± 
3.56512 with P value 0.000 and the difference was found to be statistically 
significant. 
  N145 Latency: The mean value of N145 in Migraine without Aura was 
found to be 134.5833 ± 5.45369 and in the control group it is 129.9875 ± 
8.61460 with P value 0.022 and   found to be statistically significant. 
 P100 Amplitude: P100 Amplitude mean value in Migraine without Aura was 
observed to be 5.5371 ± 2.23703 and in the control group it is 5.7975 ± 
3.27955 with P value 0.732 and the difference was found to be statistically 
insignificant. 
Brainstem Auditory Evoked Potential: (Table 5) 
              Latencies of Wave I ,III & V and the Interpeak latencies I-III , III – V & I-V 
were measured. 
 WAVE I : The mean value of wave I latency in  Migraine without Aura     
           was observed to be 1.3900±0.35864  and  in  the  control  group    
        1.1222±0.22525 with P value 0.000 and found to be statistically significant. 
 WAVE III : Wave III latency  in  Migraine without Aura was observed to 
be 3.7850 ± 0.56300 and in the control group 3.4323 ± 0.63872 with P 
value 0.029 and found to be statistically significant . 
 WAVE V: The mean value of wave V latency in Migraine without Aura 
was observed to be 6.3321±0.81817 and in the control group 
5.6510±0.91618 with P value 0.004 and found to be statistically significant. 
 I - III IPL :  
       I – III Interpeak latency in Migraine without Aura was observed to be 
2.3908 ± 0.41921 and in the control group 2.2797 ± 0.57041 with P value 
0.411 and found to be statistically insignificant. 
 III – V IPL:  
        III – V Interpeak latency in Migraine without Aura was observed to be 
2.5567±0.52122 and in the control group 2.2420 ± 0.45662 with P value 
0.014 and found to be statistically significant. 
 I – V IPL :  
        The mean value of I - V IPL in Migraine without Aura was observed 
to be 4.9529 ± 0.67163 and in the control group 4.4888 ± 0.81594 with P 
value 0.022 and found to be statistically significant.  
Comparsion of Parameters Between Migraine With Aura And Without Aura: 
(Table 6) 
            When Electrophysiological parameters(VEP N75,P100 & N145 latency and P100 
amplitude, BAEP Wave I,III & V and IPL I- III , III- V & I - V )  were compared 
 between two groups Migraine with aura and without aura , Our study results did not show 
any  significance between two groups  but  when the individual parameters were 
compared , the values of Migraine with aura are larger than Migraine without aura.   
Visual Evoked Potential : 
 VEP N75 Latency: The mean value of N75 in Migraine with Aura was 
found to be 71.5438± 3.41818 and in the Migraine without aura it is 71.4896± 
4.62653   with P value 0.968 and the difference was found to be insignificant. 
  P100 Latency: P100 Latency mean value in Migraine with Aura was 
observed to be 102.0625 ± 5.70782 and in the Migraine without aura it is   
99.9792 ± 5.06261 with P value 0.233 and the difference was found to be 
statistically insignificant. 
  N145 Latency: The mean value of   N145 in Migraine with Aura was found 
to be 136.2188 ± 10.45302   and in the Migraine without aura it is134.5833 ± 
5.45369   with P value 0.521 and   found to be statistically insignificant. 
 P100 Amplitude: P100 Amplitude mean value in Migraine with Aura was 
observed to be 6.2344 ± 3.28791 and in the Migraine without aura it is 
5.5371 ± 2.23703 with P value 0.429 and the difference was found to be 
statistically   insignificant. 
Brainstem Auditory Evoked Potential: 
              Latencies of Wave I, III & V and the Interpeak latencies I-III, III – V & I-V 
were measured. 
  WAVE I: The mean value of wave I latency in Migraine with Aura was 
observed to be 1.2725±0.29322 and in Migraine without aura it is 
1.3900±0.35864 with P value 0.283 and found to be statistically 
insignificant. 
 WAVE III: Wave III latency in Migraine with Aura was observed to be 
3.9381 ± 0.62159 and in Migraine without aura 3.7850 ± 0.56300 with P 
value 0.424 and found to be statistically insignificant. 
 WAVE V: The mean value of wave V latency in Migraine with Aura was 
observed to be 6.3444 ±1.39867 and in the Migraine without aura 
6.3321±0.81817 with P value 0.972 and found to be statistically 
insignificant. 
 I - III IPL :  
       I – III Interpeak latency in Migraine with Aura was observed to be 
2.6625 ± 0.57633 and in Migraine without aura 2.3908 ± 0.41921 with P 
value 0.092 and found to be statistically insignificant. 
 III – V IPL:   
        III – V Interpeak latency in Migraine with Aura was observed to be 
2.5906 ± 0.57130 and in Migraine without aura 2.5567±0.52122 with P 
value 0.847 and found to be statistically insignificant. 
 I – V IPL :  
        The mean value of   I - V IPL in   Migraine with Aura was observed to 
be 5.2556 ± 1.04950   and in Migraine without aura 4.9529 ± 0.67163   
with P value 0.272 and found to be statistically insignificant.  
  
 
 Table 1: Electrophysiological  findings in  the Control group (n= 40 ) 
 
PARAMETER Control (n=40) 
Min. Max. Mean S.D 
N75 62.25 78.00 70.5750 4.20058 
P100 86.50 101.25 95.1625 3.56512 
N145 112.75 163.00 129.9875 8.61460 
P100 AMPLITUDE .55 16.29 5.7975 3.27955 
WAVE I .70 1.50 1.1223 .22525 
WAVE III 2.33 5.83 3.4322 .63872 
WAVE V 3.63 8.02 5.6510 .91618 
I - III IPL 1.34 4.64 2.2798 .57041 
III - V IPL 1.30 3.72 2.2420 .45662 
I -V IPL 2.64 6.41 4.4888 .81594 
 
 
   
 
                    
  
Table 2 : Electrophysiological  findings in  the Study group Migraine without aura 
( n = 24) 
Parameters Min Max Mean Std 
deviation 
N75 63.00 83.00 71.4896 4.62653 
P100 90.00 109.50 99.9792 5.06261 
N145 125.50 149.25 134.5833 5.45369 
P100 AMPLITUDE 1.13 9.22 5.5371 2.23703 
WAVE I .61 2.09 1.3900 .35864 
WAVE III 2.76 4.93 3.7850 .56300 
WAVE V 4.74 8.45 6.3321 .81817 
I - III IPL 1.63 3.24 2.3908 .41921 
III - V IPL 1.86 4.08 2.5567 .52122 
I -V IPL 3.80 6.36 4.9529 .67163 
 
 
 
 
 
    
Table 3 :  Electrophysiological  findings in  the Study group Migraine with Aura 
( n = 16 ) 
 
Parameters Min Max Mean Std deviation 
         N75 66.50 78.25 71.5437 3.41818 
P100 93.75 114.25 102.0625 5.70782 
N145 121.00 153.00 136.2187 10.45302 
P100 
AMPLITUDE 
1.07 13.08 6.2344 3.28791 
WAVE I .57 1.72 1.2725 .29322 
WAVE III 3.03 5.11 3.9381 .62159 
WAVE V 3.01 8.21 6.3444 1.39867 
I - III IPL 1.93 3.53 2.6625 .57633 
III - V IPL 1.91 3.52 2.5906 .57130 
I -V IPL 4.01 6.63 5.2556 1.04950 
 
 
 
                       
 
       
Table 4 : Electrophysiological findings in cases( Migraine with aura ) & 
Control group 
Parameters 
Migraine  with 
Aura  
Control   
P value Mean ± SD Mean ± SD 
VEP Latency 
N75 
P100 
N145 
P100 Amplitude 
 
71.5438± 3.41818 
102.0625 ± 5.70782 
136.218 ± 10.45302 
6.2344 ± 3.28791 
 
70.5750 ± 4.20058 
95.1625±3.56512 
129.9875±8.61 
5.7975 ± 3.27955 
 
0.416 
0.000 
0.025 
0.654 
    BAEP Latency 
Wave I 
Wave III 
Wave V 
I – III IPL 
III – V IPL 
I – V IPL 
 
 
1.2725±0.29322 
3.9381 ± 0.62159 
6.3444±1.39867 
2.6625±0.57633 
2.5906±0.57130 
     5.2556±1.04950 
 
 
1.1222±0.22525 
3.4323±0.63873 
5.6510±0.91618 
2.2797±0.57041 
2.2420±0.45662 
4.4888±0.81594 
 
 
0.044 
0.009 
0.033 
0.028 
0.020 
0.005 
 
  
          P  Value > 0.05 Not significant. 
 
                        
Table 5 : Electrophysiological findings in cases( Migraine without aura ) & 
Control group 
 
Parameters 
Migraine  without 
Aura  
Control   
P value Mean ± SD Mean ± SD 
VEP Latency 
N75 
P100 
N145 
P100 Amplitude 
 
71.4896± 4.62653 
99.9792± 5.06261 
134.5833 ± 5.45369 
   5.5371 ± 2.23703 
 
70.5750 ± 4.20058 
95.1625±3.55126 
129.9875±8.61 
5.7975 ± 3.27955 
 
0.420 
0.000 
0.022 
0.732 
BAEP Latency 
Wave I 
Wave III 
Wave V 
I – III IPL 
III – V IPL 
I – V IPL 
 
1.3900 ± 0.35864 
3.7850 ± 0.56300 
6.3321 ± 0.81817 
2.3908 ± 0.41921 
2.5567 ± 0.52122 
4.9529  ±0.67163 
 
1.1222±0.22525 
3.4323±0.63873 
5.6510±0.91618 
2.2797±0.57041 
2.2420±0.45662 
4.4888±0.81594 
 
0.000 
0.029 
0.004 
0.411 
0.014 
0.022 
 
 
 
               
                         Table 6 : Electrophysiological findings in Migraine with aura &  
                                               Migraine without aura group 
 
Parameters 
Migraine  with 
Aura (n= 16) 
   Migraine without  
aura (n= 24) 
 
P value Mean ± SD Mean ± SD 
VEP Latency 
N75 
P100 
N145 
P100 Amplitude 
 
 
71.5438± 3.41818 
102.0625 ± 5.70782 
136.218 ± 10.45302 
6.2344 ± 3.28791 
 
 
71.4896± 4.62653 
99.9792± 5.06261 
134.5833 ± 5.45369 
   5.5371 ± 2.23703 
 
0.968 
0.233 
0.521 
0.429 
BAEP Latency 
Wave I 
Wave III 
Wave V 
I – III IPL 
III – V IPL 
I – V IPL 
 
 
1.2725±0.29322 
3.9381 ± 0.62159 
6.3444±1.39867 
2.6625±0.57633 
2.5906±0.57130 
     5.2556±1.04950 
 
 
1.3900 ± 0.35864 
3.7850 ± 0.56300 
6.3321 ± 0.81817 
2.3908 ± 0.41921 
2.5567 ± 0.52122 
4.9529  ±0.67163 
 
0.283 
0.424 
0.972 
0.092 
0.847 
0.272 
 
 
  
 
                                                  MIGRAINE WITH AURA 
 
           VEP N75 Latency: The mean value of N75 in Migraine with Aura was found to 
be 71.5438± 3.41818   and in the control group it is 70.5750 ± 4.20058 with P value 
0.416 and the difference was found to be insignificant. 
          N145 Latency: The mean value of N145 in Migraine with Aura was found to be 
136.2188 ± 10.45302 and in the control group it is 129.9875±8.61460 with P value 0.025 
and  found to be statistically significant.( Fig 9 )  
 
                           Fig 9: VEP N75 & N145 Latency in Migraine with aura  
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VEP P100 Latency: P100 Latency mean value in Migraine with Aura was observed to   
be 102.0625 ± 5.70782 and in the control group it is 95.1625 ± 3.56512 with P value  
0.000  and the  difference was found to be statistically significant. (Fig 10) 
   
                              Fig 10 . VEP P100 Latency in Migraine with aura 
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P100 Amplitude:  
         P100 Amplitude mean value in Migraine with Aura was observed to be 6.2344 ± 
3.27955 and in the control group it is 5.7975 ± 3.27955 with P value 0.654 and the 
difference was found to be statistically insignificant.(Fig 11 ) 
                                      Fig 11 P100 amplitude in Migraine with aura 
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BAEP: 
            WAVE I: The mean value of wave I latency in Migraine with Aura was observed 
to be 1.2725±0.29322 and in the control group 1.1222±0.22525 with P value 0.044 and 
found to be statistically significant. 
            WAVE III: Wave III latency in Migraine with Aura was observed to be 
3.9381±0.62159 and in the control group 3.4323±0.63872 with P value 0.009 and found 
to be statistically significant. 
             WAVE V: The mean value of wave V latency in Migraine with Aura was 
observed to be 6.3444±1.39867 and in the control group 5.6510±0.91618 with P value 
0.033 and found to be statistically significant. (Fig 12) 
                     Fig 12   BAEP Wave I, III, V Latencies in Migraine with aura 
 
0
1
2
3
4
5
6
7
WAVE I WAVE III WAVE V
MIGRAINE WITH AURA
CONTROL
            
 
 
          I - III IPL: I – III Interpeak latency in   Migraine with Aura was observed to be 
2.6625±0.57633 and in the control group 2.2797±0.57041 with P value 0.028 and found 
to be statistically significant. (Fig 13) 
        
Fig 13.  BAEP   Interpeak Latencies I-III in Migraine with aura 
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III – V IPL: III – V Interpeak latency in Migraine with Aura was observed to be 
2.5906±0.57130 and in the control group 2.2420±0.45662 with P value 0.020 and found 
to be statistically significant. (Fig 14) 
  
              Fig 14.  BAEP   Interpeak Latencies III- V in Migraine with aura 
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     I – V IPL: The mean value of   I - V IPL in   Migraine with Aura was observed to be 
5.2556±1.04950 and in the control group 4.4888±0.81594 with P value 0.005 and found 
to be statistically significant. (Fig 15)  
 
                   Fig 15. Interpeak Latency I - V   in Migraine with aura 
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                                  MIGRAINE WITHOUT AURA 
 
              VEP N75 Latency: The mean value of N75 in Migraine without Aura was 
found to be   71.4896± 4.62653   and in the control group it is 70.5750 ± 4.20058 with P 
value 0.420 and the difference was found to be insignificant. 
               N145 Latency: The mean value of N145 in Migraine without Aura was found 
to be 134.5833 ± 5.45369 and in the control group it is 129.9875 ± 8.61460 with P value 
0.022 and   found to be statistically significant. (Fig 16) 
                 Fig 16.  VEP N75 & N145 Latencies in Migraine without aura 
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                P100 Latency: P100 Latency mean value in Migraine without Aura was 
observed to be 99.9792 ± 5.06261 and in the control group it is 95.1625 ± 3.56512 with P 
value 0.000 and the difference was found to be statistically significant. (Fig 17) 
 
                           Fig 17.    P100 Latency in Migraine without aura 
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             P100 Amplitude: P100 Amplitude mean value in Migraine without Aura was 
observed to be 5.5371 ± 2.23703 and in the control group it is 5.7975± 3.27955 with P 
value 0.732   and the difference was found to be statistically   insignificant.  (Fig 18) 
 
                            Fig 18. P100 Amplitude in Migraine without aura 
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            BAEP : 
              WAVE I: The mean value of wave I latency in Migraine without Aura was 
observed to be 1.3900±0.35864 and in the control group 1.1222±0.22525 with P value 
0.000 and found to be statistically significant. 
             WAVE III : Wave III latency  in  Migraine without Aura was observed to be 
3.7850 ± 0.56300 and in the control group 3.4323 ± 0.63872 with P value 0.029 and 
found to be statistically significant . 
              WAVE V: The mean value of wave V latency in Migraine without Aura was 
observed to be 6.3321±0.81817 and in the control group 5.6510±0.91618 with P value 
0.004 and found to be statistically significant.(Fig 19 ) 
Fig 19.  BAEP Waves I, III, V Latencies in Migraine without aura 
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  I - III IPL:    I – III Interpeak latency in Migraine without Aura was observed to be 
2.3908 ± 0.41921 and in the control group 2.2797 ± 0.57041 with P value 0.411 and 
found to be statistically insignificant. (Fig 20) 
 Fig 20.  BAEP Interpeak Latency I-III in Migraine without aura 
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          III – V IPL: III – V Interpeak latency in Migraine without Aura was observed to 
be 2.5567±0.52122 and in the control group 2.2420 ± 0.45662 with P value 0.014 and 
found to be statistically significant. (Fig 21) 
 
                           Fig 21. Interpeak Latency III – V in Migraine without aura 
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  I – V IPL:  The mean value of I - V IPL in Migraine without Aura was observed to be 
4.9529 ± 0.67163 and in the control group 4.4888 ± 0.81594 with P value 0.022 and 
found to be statistically significant. (Fig 22) 
             
                       Fig 22. Interpeak Latency I – V in Migraine without aura 
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                      MIGRAINE WITH AURA & MIGRAINE WITHOUT AURA 
 
      VEP N75 Latency: The mean value of N75 in Migraine with Aura was found to be 
71.5438± 3.41818 and in the Migraine without aura it is 71.4896 ± 4.62653 with P value 
0.968 and the difference was found to be insignificant. 
      N145 Latency: The mean value of N145 in Migraine with Aura was found to be 
136.2188 ± 10.45302 and in the Migraine without aura it is134.5833 ± 5.45369 with P 
value 0.521 and found to be statistically insignificant. (Fig 23) 
 
                    Fig 23. VEP N75 & N145 in study group 
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P100 Latency:  
       P100 Latency mean value in Migraine with Aura was observed to be 102.0625 ± 
5.70782 and in the Migraine without aura it is 99.9792 ± 5.06261 with P value 0.233 and 
the difference was found to be statistically insignificant. (Fig 24) 
                                  Fig 24. P100 latency in study group 
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 P100 Amplitude:  
        P100 Amplitude mean value in Migraine with Aura was observed to be 6.2344 ± 
3.28791 and in the Migraine without aura it is 5.5371 ± 2.23703 with P value 0.429 and 
the difference was found to be statistically insignificant. (Fig 25) 
                                 Fig 25.  P100 Amplitude in study group 
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BAEP:  
 WAVE I: The mean value of wave I latency in Migraine with Aura was 
observed to be 1.2725±0.29322 and in Migraine without aura it is 
1.3900±0.35864 with P value 0.283 and found to be statistically 
insignificant. 
 WAVE III: Wave III latency in Migraine with Aura was observed to be 
3.9381 ± 0.62159 and in Migraine without aura 3.7850 ± 0.56300 with P 
value 0.424 and found to be statistically insignificant. 
 WAVE V: The mean value of wave V latency in Migraine with Aura was 
observed to be 6.3444 ±1.39867 and in the Migraine without aura 
6.3321±0.81817 with P value 0.972 and found to be statistically 
insignificant. (Fig 26 ) 
                             Fig 26. Wave I, III & V Latency 
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I - III IPL :  
       I – III Interpeak latency  in  Migraine with Aura was observed to be 2.6625 ± 
0.57633 and in Migraine without aura was 2.3908 ± 0.41921 with P value 0.092 and 
found to be statistically insignificant .( Fig 27 ) 
                   Fig 27.  I-III IPL in study group 
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III – V IPL:  
  III – V Interpeak latency in Migraine with Aura was observed to be 2.5906 ± 0.57130 
and in Migraine without aura was 2.5567±0.52122 with P value 0.847 and found to be 
statistically insignificant.( Fig 28 ) 
                                       Fig 28.   III-V IPL in study group 
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I – V IPL: 
   The mean value of I - V IPL in Migraine with Aura was observed to be 5.2556 ± 
1.04950 and in Migraine without aura 4.9529 ± 0.67163   with P value 0.272 and found 
to be statistically insignificant.  (Fig 29) 
 
                                        Fig 29.  I- V IPL in study group 
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 DISCUSSION 
 
 
 
 
 
 
 
 
                      DISCUSSION   
             In the present study, the Electrophysiological parameters are evaluated in 
Migraine patients with and without Aura and in 40 control group healthy volunteers. 
             Migraine, the most common Neurological disorder is associated with substantial 
functional impairment, involving both physical and emotional ramifications. Migraine 
can best be explained as a „Brain state ʼ in which the cellular and vascular functional 
changes occur at the same time due to dysfunction of subcortical structures, brainstem 
and diencephalic nuclei that modulate sensory inputs. These nuclei act as a „Migraine 
Mediatorʼ whose dysfunction will lead to abnormal perception and activation of TVS 
which then activate the central structures.  
                Thus, Migraine is mainly due to TVS activation generated within the brain 
without a peripheral sensory input. Migraine is the central sensory processing disorder,   
there is dysfunction of descending brainstem pain modulatory system. The 
hyperexcitability of the nociceptive circuitry downstream is responsible for the central 
sensitization in Migraine patients.
(69)
 
             In our present study, patients with Migraine either with aura or without aura   
differ significantly in various electrophysiological parameters.  
         Our VEP study results showed that P100 and N145 latencies were significantly 
prolonged with p < 0.05   in both Migraine with and without Aura  when compared with 
controls whereas P100 Amplitude  was increased in study group especially in cases with 
Aura than the control group but it was not statistically significant  P=0.654 . 
 
       
       The results of  the present study agreed with EL Shater et al., Laila EL Mosly et al ., 
Kennard et al ., Khalil et al ., Mariani et al ., Drake et al ., Bockowski L et al ., 
    In the study conducted by EL Shater et al.,
(35)
 showed significant prolongation of 
P100 latency only in Migraine with aura patients and there was no significant difference 
in P100 Amplitude between patients and controls. These changes were found to have a 
structural basis, due to repeated attacks resulting in ischemia and proposed that there is 
subtle neuronal damage in the visual system in Migraine with aura patients. These results 
were consistent with our present study.  
     Kennard et al., 
(40) 
also reported prolonged P100 latency in Migraine patients and 
explained it to have a structural basis. Khalil et al., also found the same results but 
suggested the prolonged latencies are constitutional due to synaptic delay. Similar results 
were found in our study. 
     Laila EL Mosly et al .,
(7)
 also found significant prolongation of P100 latency with no 
change in P100 amplitude, these changes were explained to be due to Occipital cortex 
dysfunction in Migraine patients. These results are in accordance with our present study.  
      Drake et al .,
(49)
 found significant prolongation of  P100 & N145 latencies in 
Migraine without aura cases due to dysfunction of  brainstem centers probably related to 
endorphin or serotonin neurotransmission.  Mariani et al ., 
(47)
 reported an increase in  
P100 latency in Migraine with & without aura whereas Amplitudes were  quite dispersed 
among patients and controls. Suggested the alterations in the monoamine neuromediators   
are responsible for these changes.  Similar findings were observed in our study. 
            Bockowski L et al ., 
(37) 
found significant prolongation of P100 latency whereas 
amplitudes N1-P100 & P100-N2 were prolonged in Migraine children  than the children 
with tension type headache. They also reported that these amplitudes were lower in 
Migraine with aura when compared with Migraine without aura patients. These changes 
were due to visual dysfunction that might be secondary to a loss of inhibitory GABAergic 
interneurons in the visual cortex from repeated parenchymal insults. P100 latency showed 
similar findings in our study. 
           N.Ashjazadeh , B Varavipour 
(38)
 reported significant prolongation of P100 
latency in classic Migraine patients with no change in the Amplitude due to subtle 
neuronal damage in the visual system  of Migraine patients from repeated transient 
ischemia , probably due to constitutional change. These results were consistent with our 
present study. 
           Nofal M Khalil , Nigel J Legg , Duncan J Anderson 
(6)
found similar results due 
to synaptic delay . Research work also showed positive correlation between disease 
duration and changes in amplitude of P100.
  
The   results of P100 latency were consistent 
with our present study.  
        Pedro.F Moreira Filho , Adalmir M. Dantas 
(34)
 found significant prolongation in 
P100 latency in Migraine without aura patients due to alterations in Monoamine 
neuromediators.  Similar results were found in our study. 
     Thus, Migraine patients with and without aura had significant prolongation of  P100  
& N145 latency due to hyperexcitability of the cortex in Migraine patients even between 
attacks and due to synaptic delay. 
           Our BAEP study   reports showed significant prolongation of latencies of Wave I, 
III & V with P <0.05 in Migraine patients when compared with controls. Also, the 
interpeak latencies I- III, III- V & I- V were significantly prolonged in study group, 
Migraine with aura than the controls. In Migraine without Aura III- V & I- V were 
significantly prolonged. 
The results of present study were consistent with  D Koushal ,S Sanjay Munjal , M Modi; 
N Panda , Firat Y et al., Schalke HP et al ., Anil K Dash et al ., Laila EL Mosly et al ., 
Drake et al ., Bayazit et al .,  
        D Koushal ,S Sanjay Munjal , M Modi , N Panda 
(50)
 studied  BAEP in Migraine 
patients and found significant prolongation of latencies of wave I , III & V and in the IPL    
I - III  & III- V  due to involvement of brainstem structures as well  as due to activation 
of brainstem in Migraine patients . Similar results were found in our study.  
     Schalke HP et al ., 
(52)
 found the same results and reported that there is a permanent 
impairment of brainstem function in Migraine patients. These findings are consistent with 
our present study. 
         Firat Y et al., 
(51)
 studied in paediatric Migraine patients and found prolongation of 
wave V latency & I- V IPL in study group due to transient impairment of brainstem   
function in Migraine patients. 
            Anil K Dash et al ., 
(53)
  found significant prolongation  of latencies of Wave I , 
III, V & I-III IPL, III- V IPL & I – V IPL . The study concluded that there is brainstem 
involvement in Migraine and BAEP are the earliest indicator of impending auditory 
 involvement in patients with Migraine. These results are in accordance with our present 
study. 
           Laila EL Mosly  et al ., 
(7)
 found prolongation in wave III & V and the I-III , I – V 
IPL due to hyperexcitability of the cerebral cortex. Bayazit Y et al., 
(55)
 found 
prolongation of latency of wave I, III & V and the IPL III- V. Similar results were found 
in our study. 
         Sheriya A Hamed , Amal Mohammed Elatter 
(53)
 found prolongation of wave III 
latency and the IPL I-III , III – V & I – V. This study suggests that there is permanent 
vestibular damage involving either central or peripheral pathways. Similar results were 
observed in our study. 
                   Thus , Migraine patients with and without aura show significant prolongation 
of latency in Electrophysiological studies probably due to  subtle neuronal damage within 
the visual system especially in patients with aura  due to recurrent cerebral hypoperfusion 
and due to cortical hyperexcitability. These findings suggest dysfunction of neuronal 
excitability due to defective neurotransmitter signaling and cerebral bioelectrical 
dysrhythmia. 
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                                              CONCLUSION 
                The present study results show that there is involvement of the central nervous 
system Visual pathway and the Brainstem in Migraine patients. The Migraine patients 
show prolongation of latency in Electrophysiological studies. 
               Migraine patients with aura and without aura show significant prolongation of   
P100, N145 Latency with no change in P100 amplitude and in BAEP the latencies of 
waves I , III & V and the IPLs I-III , III- V & I-V are prolonged. These findings suggest 
there is defect in the central processing of visual function and BAEP alterations suggest 
involvement of Brainstem structures during   Migraine attack.   
                Thus, VEP and Auditory brainstem evoked responses are considered as useful, 
non-invasive, reliable & diagnostic techniques for better understanding the   
Neurophysiological processes involved in Migraine patients which aid in the selection of 
adequate, effective treatment in Migraine subjects. 
             However, further studies are needed to compare the duration of the disease with 
the changes in the Electrophysiological study and to explain the role of   
Neuromodulatory centers in the brainstem in pathophysiology of Migraine. Then, the role 
of pattern reversal check size on VEP parameters in Migraine patients and lack of 
habituation during prolonged stimulation should be evaluated. 
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        ANNEXURES 
 
 
 
 
 
 
 
 
 
 
  
                                                     ABBREVIATIONS 
 VEP : Visual evoked potential 
 BAEP : Brainstem auditory evoked potential  
 OCD : Obsessive  compulsive disorder 
 IHS : International headache society 
 MIDAS : Migraine disability assessment score 
 MMSE :   Mini mental state examination 
 CSD : Cortical spreading depression  
 TVS: Trigeminal Vascular system 
 TCC : Trigeminal cervical component 
 ERP : Event related potential 
 EP : Evoked potential 
 IPL : Interpeak latency 
 ABR : Auditory brainstem response 
 
 
 
 
 
  
 
                                                   INFORMED CONSENT  
  
            Dr. R.Sowmiya, Post graduate student in the Department of Physiology, 
Thanjavur Medical College, Thanjavur is doing the study entitled „Evaluation of Visual 
evoked potential and Auditory evoked potential in Migraine‟. The procedure of the 
study has been explained   to me in my own language. I understand that there is no risk 
involved in the above procedure and it is purely non- invasive. I hereby give my consent 
to participate in this study. The data obtained here may be used for research and 
publication. 
 
Station:                                                                                     Signature of the subject 
    Date:                                                                                                  
                                                                                                 Signature of the Investigator 
 
 
                                                
 
                                                PROFORMA 
     EVALUATION  OF VISUAL  EVOKED POTENTIAL & BRAINSTEM    
                    AUDITORY   EVOKED POTENTIAL IN MIGRAINE 
NAME:                                     AGE:                            SEX: 
ADDRESS:                                                     OCCUPATION: 
PRESENT HISTORY: 
     H/O Headache  : 
              Duration   : 
               Frequency: 
     HISTORY SUGGESTIVE OF AURA: 
                 H/O Numbness / Tingling 
                 H/O Double vision 
                 H/O Flash of light 
                 H/O Tinnitus  
                 H/O Speech disturbances  
                 H/O Floaters 
      H/O Nausea / Vomiting / Giddiness 
      H/O Ear discharge 
      H/O Visual disturbances 
PAST HISTORY: 
                   H/O Hypertension / Diabetes / Thyrotoxicosis 
 PERSONAL HISTORY: 
FAMILY HISTORY: 
MENSTRUAL HISTORY: 
DRUG HISTORY: 
GENERAL EXAMINATION: 
Pallor:            Icteric:             Cyanosis:              Clubbing:           Lymphadenopathy: 
VITAL SIGNS:  
Pulse:                                    Respiratory rate: 
BP:                                         Vision: 
Examination of CVS: 
Examination of RS: 
Examination of Abdomen: 
Examination of CNS: 
Examination of Eye:          Right:                     Left: 
Examination of Ear:          Right:                       Left: 
Examination of Nose& Paranasal sinuses: 
Examination of Teeth & Oropharynx: 
DIAGNOSIS: Migraine with aura / Migraine without aura 
ROUTINE INVESTIGATIONS: 
                 Blood sugar : 
                  Urea            : 
                   
 
 VEP : 
 
        N75 
    Latency 
     P100 
    Latency 
     N145 
   Latency 
P100 
Amplitude 
                  
LEFT EYE 
    
 
 
RIGHT EYE 
    
 
 
 
BAER: 
      
 Wave I  Wave III Wave V  I – III 
IPL 
III – V 
IPL 
 I – V IPL 
LEFT EAR 
 
      
RIGHT 
EAR 
 
      
 
 
 
 
 
 
 
  
 
 
 
      
          MASTER CHART 
 
 
 
 
                            
 
                        Visual Evoked Potential and Brainstem Auditory Evoked Potential in Migraine with Aura Cases 
S.No 
 
Age/ 
Sex 
VEP N75 
Latency(ms) 
VEP P100 
Latency (ms) 
VEP  N145 
Latency (ms) 
VEP P100 
Amplitude(µv ) 
 
                   BAEP  LT 
 
                            BAEP RT 
LT RT LT RT LT RT LT RT I III V I-III III-V I-V I III V I-III III-V I-V 
1 31/F 73.5 64.5 110 111 154 152 8.62 8.93 1.75 3.82 6.12 2.07 2.3 4.37 0.98 3.2 5.48 2.22 2.28 4.5 
2 44/F 64.5 70 115.5 113 144.5 134 6.15 6.96 1.2 3.25 5.2 2.05 1.95 4 0.85 2.82 4.88 1.97 2.06 4.03 
3 30/M 77 70.5 103.5 100.5 136 132.5 5.71 7.88 1.4 3.82 8.07 2.42 4.25 6.67 1.32 3.82 6.62 2.5 2.8 5.3 
4 43/F 70.5 75.5 105 96 148 133.5 1.8 0.34 1.4 4.4 6.18 3 1.78 4.78 1.05 2.42 4.92 1.37 2.5 3.87 
5 19/F 66 71 98 101 145.5 152 2.51 1.53 0.8 4.05 6.42 3.25 2.37 5.62 0.85 4.65 8.43 3.8 3.78 7.58 
6 19/F 70.5 76 110.5 111 139.5 141 12 14.17 1.72 5.7 .78 3.98 3.08 7.06 1.42 4.53 7.65 3.08 3.12 6.2 
7 27/F 79 68 93 104.5 139 136 6.98 6.17 0.35 4.55 6.4 4.2 1.85 6.05 0.8 3.58 7.4 2.78 3.82 6.6 
8 45/F 75.5 70.5 105.5 103 128 124 6.44 7.11 0.78 2.58 4.85 1.8 2.27 4.07 1.5 4.53 7.2 3.03 2.67 5.7 
9 42/M 71 72.5 96 99 125 134 6.14 3 1.3 3.25 5.1 1.95 1.85 3.8 1.23 3.15 5.5 1.92 2.35 4.27 
10 47/F 77.5 79 100.5 100.5 121 121 6.23 2.38 1.65 3.75 5.78 2.1 2.03 4.13 1.23 3.35 5.2 2.12 1.85 3.97 
11 29/F 66 67 98.5 96.5 126 126.5 7.06 10.87 1.2 3.88 5.88 2.68 2 4.68 1.45 2.98 4.8 1.53 1.82 3.35 
12 49/F 73.5 74 100 101.5 126 121.5 8.64 3.12 1.1 4.62 6.32 3.52 1.7 5.22 1.82 4.15 6.42 2.33 2.27 4.6 
13 42/M 75 78.5 91.5 96 116.5 135.5 4.6 1.33 1.4 3.78 7.02 2.38 3.24 5.62 2.05 5.85 9.2 3.8 3.35 7.15 
14 49/F 66 70.5 100.5 97 133 133 12.53 11.61 1.38 3.32 5.7 1.94 2.38 4.32 1.1 4.85 9.2 3.75 4.35 8.1 
15 19/F 60 77 103.5 109.5 150 145.5 5.07 4.03 1.05 4.42 6.85 3.37 2.43 5.8 1.4 3.3 5.68 1.9 2.38 4.28 
16 30/F 72.5 63.5 97.5 94.5 156.5 124.5 9.68 14.9 0.88 4.32 7.5 3.44 3.18 6.62 2.38 5.42 8.35 3.04 2.93 5.97 
 
 
  
                                                                                      
                  Visual Evoked Potential and Brainstem Auditory Evoked Potential in Migraine without Aura Cases 
  
S.No 
 
Age/ 
Sex 
VEP N75 
Latency(ms) 
VEP P100 
Latency (ms) 
VEP  N145 
Latency (ms) 
VEP P100 
Amplitude(µv ) 
 
BAEP  LT 
 
BAEP RT 
LT RT LT RT LT RT LT RT I III V I-III III-V I-V I III V I-III III-V I-V 
1 36/F 60 69.5 90.5 102 121 131 3.57 2.33 0.82 3.35 6 2.53 2.65 5.18 1.45 3.65 5.22 2.2 1.57 3.77 
2 38/M 76 70 92 92 129 132 1.68 2.01 1.65 3.12 4.68 1.47 1.56 3.03 1.85 3.98 6.45 2,15 2.47 4.6 
3 33/F 73 67 103.5 93 133.5 132.5 3.53 6.3 1.8 4.85 7.58 3.05 2.73 5.78 0.9 2.82 4.58 1.92 1.76 3.68 
4 33/F 68.5 70 95 95 125.5 137 6.37 8.57 0.75 3.32 9.15 2.57 5.83 8.4 2.33 3.82 6.15 1.49 2.33 3.82 
5 30/F 66.5 65.5 104 100.5 131 131 7.51 7.26 1.05 3.88 6.75 2.83 2.87 5.7 1.32 4.78 8.25 3.46 3.47 6.93 
6 34/F 74.5 70 103.5 98 141.5 145 8.53 9.92 1.35 3.68 7.95 2.33 4.27 6.6 0.9 3.5 5.03 2.6 1.53 4.13 
7 19/F 73 71 101.5 101 128.5 142.5 9.74 8.59 0.85 3.02 5 2.17 1.98 4.15 1.42 3.8 5.8 2.38 2 4.38 
8 52/M 82 74.5 107 102.5 134.5 137.5 6.1 4.86 0.6 2.75 4.68 2.15 1.93 4.08 0.62 3 4.8 2.38 1.8 4.18 
9 19/F 74 70 87.5 92.5 137 139.5 5.81 4.42 0.65 2.8 5.05 2.15 2.25 4.4 1.5 3.7 5.9 2.2 2.2 4.4 
10 19/F 70.5 69.5 105 99.5 146 131.5 4.53 5.08 1.15 2.72 5.18 1.57 2.46 4.03 1.15 3.35 5.68 2.2 2.33 4.53 
11 33/F 75 73.5 98.5 94 136.5 132.5 5.5 5.77 1 3.72 6.02 2.72 2.3 5.02 1.27 4.15 6.62 2.88 2.47 5.35 
12 23/F 76 73.5 109 103 137 135 10.92 2.56 1.7 5.25 7.55 3.55 2.3 5.85 1.85 4.58 6.22 2.73 1.64 4.37 
13 28/F 74.5 65.5 97 97 136.5 149.5 0.27 8.66 1.52 3.65 5.98 2.13 2.33 4.46 1.92 4 6.95 2.08 2.95 5.03 
14 32/F 65 76 99 106 129 137 7.29 9.57 0.78 2.95 5.22 2.17 2.27 4.44 1.4 5.72 8.02 4.32 2.3 6.62 
15 33/F 59.5 66.5 95.5 95.5 123 128 3.85 6.05 1.58 3.82 7.08 2.24 3.26 5.5 1.68 4.1 6.42 2.42 2.32 4.74 
16 44/F 68.5 69 96 95 130.5 130.5 9.57 8.28 1.98 3.98 7.72 2 3.74 5.74 2.2 5.88 9.18 3.68 3.3 6.98 
17 33/M 72 68 100.5 102.5 137.5 141.5 10.82 3.46 0.92 2.98 5.1 2.06 2.12 4.18 1.3 3.5 7 2.2 3.5 5.7 
18 36/F 77.5 85.5 102 105.5 136 129 3.56 4.85 1.08 2.7 5.68 1.62 2.98 4.6 1.18 2.82 5.48 1.64 2.66 4.3 
19 26/F 76 65 91 93.5 139 123 4.99 2.47 1.55 4.58 7.52 3.03 2.94 5.97 0.95 3.25 5.95 2.3 2.7 5 
20 36/F 83 83 105.5 103 125.5 137 1.06 1.21 1.58 3.68 6.1 2.1 2.42 4.52 1.9 3.95 6.48 2.05 2.53 4.58 
21 29/F 66 68 94 111.5 147.5 151 6.53 3.43 1.82 3.62 6.08 1.8 2.46 4.26 1.5 4.62 7.82 3.12 3.2 6.32 
22 42/F 75.5 67 101.5 107.5 134 134 2.29 3.09 1.88 4.05 6.35 2.17 2.3 4.47 1.02 3.3 5.52 2.28 2.22 4.5 
23 39/F 80 65 110 109 132.5 139 8.23 6.3 2.6 4.92 7.35 2.32 2.43 4.75 1.52 3.92 6.52 2.4 2.6 5 
24 33/F 76 66.5 105.5 105.5 135 126.5 11.09 0.12 1.2 4.08 5.92 2.88 1.84 4.72 1.8 4.18 6.92 2.38 2.74 5.12 
 
  
  
                                      Visual Evoked Potential and Brainstem Auditory Evoked Potential in Controls 
  
 
S.No 
 
Age/ 
Sex 
VEP N75 
Latency(ms) 
VEP P100 
Latency (ms) 
VEP  N145 
Latency (ms) 
VEP P100 
Amplitude(µv ) 
 
BAEP  LT 
 
BAEP RT 
LT RT LT RT LT RT LT RT I III V I-III III-V I-V I III V I-III III-V I-V 
1 40/F 64.5 64.5 90.5 89.5 143.5 126 10.2 11.87 1.35 3.4 5.42 2.05 2.02 4.07 1.7 3.95 5.75 2.25 1.8 4.05 
2 40/F 71 73 91.5 91 132.5 130.5 9.77 9.55 1.65 3.85 7.88 2.2 4.03 6.23 1 5.08 7.05 4.08 1.97 6.05 
3 31/M 66 68.5 89 90.5 112.5 113 6.51 5.63 1.82 6.15 8.05 4.33 1.9 6.23 0.57 5.52 8 4.95 2.48 7.43 
4 21/F 68.5 67.5 98 92 128 124 5.47 0.97 1 2.58 5.82 1.58 3.24 4.82 0.85 2.45 4.05 1.6 1.6 3.2 
5 44/F 79 60.5 98.5 92 131.5 134.5 3.56 6.63 0.8 2.7 4.28 1.9 1.58 3.48 0.8 2.65 4.5 1.85 1.85 3.7 
6 40/F 76.5 77 98 98.5 136.5 137 0.26 1.89 0.6 2.6 4.6 2 2 4 1.4 3.3 5.42 1.9 2.12 4.02 
7 40/F 74 77 98 102.5 137 138.5 6.29 6.28 0.85 2.98 5.98 2.13 3 5.13 1.05 3.38 5.05 2.33 1.67 4 
8 54/M 76 80 89 92.5 119 122.5 0.75 1.3 0.78 2.08 3.38 1.3 1.3 2.6 1.2 2.58 3.88 1.38 1.3 2.68 
9 42/F 68.5 66 99.5 96 129 123.5 3.24 7.09 1.2 2.6 3.92 1.4 1.32 2.72 0.82 3 6.4 2.18 3.4 5.58 
10 55/F 65 68.5 98 97 128 124 6.37 9.05 1.05 3.6 5.62 2.55 2.02 4.57 0.95 3.6 7.4 2.73 3.72 6.45 
11 23/F 70.5 70.5 97 93.5 127.5 123 8.57 6.36 1.48 5.48 8.65 4 3.17 7.17 1.02 3.9 6 2.88 2.1 4.98 
12 19/F 84 64 95 102 126 143 14.09 2.24 0.68 3.18 6.25 2.5 3.07 5.57 0.72 3.72 6.92 3 3.2 6.2 
13 27/F 71.5 68 97.5 103.5 146 141.5 7.42 10.88 0.9 3.18 5.55 2.28 2.37 4.65 1 5.82 9.02 4.82 3.2 8.02 
14 35/F 66.5 68.5 97 98.5 143.5 130.5 16.11 16.47 1.02 3.12 4.9 2.1 1.78 3.88 1.23 3.2 5.2 1.97 2 3.97 
15 32/F 72.5 70.5 96 95 129.5 121.5 5.8 3.5 1.3 3.45 5.88 2.15 2.43 4.58 0.6 3.25 6.02 2.65 2.77 5.42 
16 27/M 79 73.5 102 97.5 133 125.5 3.13 7.03 1.18 3.38 5.7 2.2 2.32 4.52 0.62 2.5 4.62 1.88 2.12 4 
17 20/M 76 77.5 100 102.5 117 143 1.76 3.87 0.57 3.62 6.7 3.05 3.08 6.13 1.25 3.58 7.95 2.33 4.37 6.7 
18 47/F 70.5 73.5 100.5 98.5 130.5 135 6.93 1.51 1.25 3.88 6.5 2.63 2.62 5.25 1.7 3.12 4.47 1.42 1.35 2.77 
19 39/F 70 74 95 93.5 136 132 8.44 4.52 1.55 4.5 7.42 2.95 2.92 5.87 1.12 3.18 5.12 2.06 1.94 4 
20 37/F 67.5 73.5 92.5 95.5 133 123.5 3.94 0.4 1.35 3.9 5.72 2.55 1.82 4.37 1.1 3.1 5.88 2 2.78 4.78 
                                 
 
                                   
                                    Visual Evoked Potential  And  Brainstem Auditory Evoked Potential in  Controls 
 
 
S.N0 
 
Age/ 
Sex 
VEP N75 
Latency(ms) 
VEP P100 
Latency (ms) 
VEP  N145 
Latency (ms) 
VEP P100 
Amplitude(µv ) 
 
BAEP  LT 
 
BAEP RT 
LT RT LT RT LT RT LT RT I III V I-III III-V I-V I III V I-III III-V I-V 
21 38/F 63 63.5 92 93 131.5 130.5 6.83 3.9 0.78 2.98 5.22 2.2 2.24 4.44 0.9 2.98 4.95 2.08 1.97 4.05 
22 44/F 79 64 101 96 121.5 126 1.66 9.39 1.05 2.78 5.03 1.73 2.25 3.98 1.92 4.08 5.5 2.16 1.42 3.58 
23 25/F 72.5 75 92.5 97 132 134.5 1.03 4.57 1.52 3.75 6 2.23 2.25 4.48 1.05 3.9 5.52 2.85 1.62 4.47 
24 31/F 66.5 75.5 93.5 96.5 129.5 128.5 0.34 0.76 1.68 3.2 4.75 1.52 1.55 3.07 1.42 3.75 5.25 2.53 1.5 3.83 
25 39/F 67 64 93.5 92 120.5 123.5 9.68 1.89 1.62 3.48 5.22 1.86 1.74 3.6 0.98 3.85 5.78 2.87 1.93 4.8 
26 27/F 74 78 100 92 144.5 141 4.02 10.33 1.75 3.82 6.2 2.07 2.38 4.45 0.95 3.12 5.35 2.17 2.23 4.4 
27 29/F 69 74 96.5 104 167.5 158.5 1.77 1.57 1.4 3.3 5.42 1.9 2.12 4.02 1.23 3.52 6.02 2.29 2.5 4.79 
28 40/M 65.5 69 83 90 131 136 1.95 2.99 1.82 3.8 6.08 1.98 2.28 4.26 0.98 3.05 5.35 2.07 2.3 4.37 
29 45/F 71.5 73.5 92.5 92 127 121 2.41 5.06 0.9 2.65 4.72 1.75 2.07 3.82 1.05 3.55 3.85 2.5 2.3 4.8 
30 26/F 75.5 73.5 99.5 98 146.5 136 6.84 5.17 1.23 2.58 3.8 1.35 1.22 2.57 0.88 3.45 5.98 2.57 2.53 5.1 
31 25/F 65.5 69 95 100 126.5 132 14.29 6.08 0.78 2.48 4.95 1.7 2.47 4.17 1.45 3.68 5.75 2.23 2.07 4.3 
32 25/F 70 77 91 91 136.5 120.5 8.59 6.18 1.82 4.32 6.65 2.5 2.33 4.83 0.7 3.18 4.85 2.48 1.67 4.15 
33 50/M 65 59.5 99 96 134.5 123 4.65 6.39 1.52 3.85 5.78 2.33 1.93 4.26 1.35 2.55 4.4 1.2 1.85 3.05 
34 43/F 68.5 68.5 92.5 98 123 127 5.8 5.07 0.78 1.92 5.45 1.14 3.53 4.67 0.8 3.45 5.25 2.65 1.8 4.45 
35 29/F 75.5 77.5 93 97.5 120 118.5 3.09 4.58 1.05 3.15 5.55 2.1 2.4 4.5 0.95 4.7 7.72 3.75 3.02 6.77 
36 44/F 63.5 70.5 93.5 91 125.5 117.5 10.17 3.25 1.58 3.78 5.98 2.2 2.2 4.4 0.98 3.38 5.6 2.4 2.22 4.62 
37 19/F 80 63 91 83.5 122 112.5 5.17 5.81 0.82 2.52 5.1 1.7 2.58 4.28 1.32 2.95 4.65 1.63 1.7 3.33 
38 34/F 72 77 95 89 126 120 3.28 2.17 1.82 4.03 6.35 2.21 2.32 4.53 0.45 3.12 4.9 2.67 1.78 4.45 
39 39/F 64 61.5 96.5 104 127 126 8.59 0.12 1.92 3.7 5.22 1.86 1.44 3.3 0.72 2.42 4.8 1.7 2.38 4.08 
40 53/F 65 67 97 96 126 133.5 4.35 1.35 1.3 3.75 5.28 2.45 1.53 3.98 0.75 3.02 5.2 2.27 2.18 4.45 
 
